id,indicator_code,spatial_dim_type,iso_code,region_code,time_dim_type,region,dim1type,dim1,year,dim2type,dim2,dim3type,dim3,data_source_dim_type,data_source_dim,value,numeric_value,low,high,comments,date,time_dimension_value,time_dimension_begin,time_dimension_end,country,indicator_name,language,title
6688,TB_rdst_num,COUNTRY,BLR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,499,499,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Belarus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
11517,TB_rdst_num,COUNTRY,TTO,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,10,10,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Trinidad and Tobago,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
28960,TB_rdst_num,COUNTRY,GRL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,5,5,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Greenland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
49706,TB_rdst_num,COUNTRY,GUM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Guam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
51500,TB_rdst_num,COUNTRY,TUR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,297,297,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,TÃ¼rkiye,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
57613,TB_rdst_num,COUNTRY,TCD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,360,360,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Chad,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
58445,TB_rdst_num,COUNTRY,ZMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,16 922,16922,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Zambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
75656,TB_rdst_num,COUNTRY,MMR,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,33 246,33246,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Myanmar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
75780,TB_rdst_num,COUNTRY,CRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,312,312,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Costa Rica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
84569,TB_rdst_num,COUNTRY,SGP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,55,55,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Singapore,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
89832,TB_rdst_num,COUNTRY,NRU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Nauru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
91965,TB_rdst_num,COUNTRY,BHR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,112,112,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Bahrain,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
92675,TB_rdst_num,COUNTRY,HND,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,202,202,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Honduras,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
95910,TB_rdst_num,COUNTRY,TCA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Turks and Caicos Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
98305,TB_rdst_num,COUNTRY,BIH,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,43,43,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bosnia and Herzegovina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
101722,TB_rdst_num,COUNTRY,SLB,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Solomon Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
102712,TB_rdst_num,COUNTRY,BRN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,14,14,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Brunei Darussalam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
106493,TB_rdst_num,COUNTRY,DMA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Dominica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
108588,TB_rdst_num,COUNTRY,IND,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,156 428,156428,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,India,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
110914,TB_rdst_num,COUNTRY,OMN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,218,218,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Oman,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
128195,TB_rdst_num,COUNTRY,GHA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,8877,8877,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Ghana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
132826,TB_rdst_num,COUNTRY,GMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Gambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
143039,TB_rdst_num,COUNTRY,AZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1245,1245,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Azerbaijan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
161449,TB_rdst_num,COUNTRY,NGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,64 505,64505,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Nigeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
164742,TB_rdst_num,COUNTRY,BHS,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bahamas,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
171974,TB_rdst_num,COUNTRY,PYF,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,French Polynesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
180685,TB_rdst_num,COUNTRY,MNE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,55,55,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Montenegro,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
183369,TB_rdst_num,COUNTRY,COM,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Comoros,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
186835,TB_rdst_num,COUNTRY,TZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1080,1080,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,United Republic of Tanzania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
188894,TB_rdst_num,COUNTRY,SYC,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Seychelles,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
201032,TB_rdst_num,COUNTRY,TKL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Tokelau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
208494,TB_rdst_num,COUNTRY,GNB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,17,17,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Guinea-Bissau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
208916,TB_rdst_num,COUNTRY,PER,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,2217,2217,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Peru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
212793,TB_rdst_num,COUNTRY,THA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,11 983,11983,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Thailand,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
214568,TB_rdst_num,COUNTRY,CMR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1447,1447,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Cameroon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
216809,TB_rdst_num,COUNTRY,BHR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bahrain,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
226427,TB_rdst_num,COUNTRY,COM,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,68,68,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Comoros,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
229074,TB_rdst_num,COUNTRY,VEN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,240,240,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
233678,TB_rdst_num,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,69,69,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Saudi Arabia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
238582,TB_rdst_num,COUNTRY,HUN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,28,28,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Hungary,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
239469,TB_rdst_num,COUNTRY,VNM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,38 689,38689,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Viet Nam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
246478,TB_rdst_num,COUNTRY,FJI,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,120,120,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Fiji,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
285251,TB_rdst_num,COUNTRY,PRT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,39,39,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Portugal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
295151,TB_rdst_num,COUNTRY,CYP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,33,33,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cyprus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
309254,TB_rdst_num,COUNTRY,HUN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,243,243,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Hungary,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
313973,TB_rdst_num,COUNTRY,ARG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,495,495,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Argentina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
314647,TB_rdst_num,COUNTRY,ISL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Iceland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
329476,TB_rdst_num,COUNTRY,AGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,6499,6499,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Angola,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
339780,TB_rdst_num,COUNTRY,GRC,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,175,175,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Greece,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
341701,TB_rdst_num,COUNTRY,CHN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,248 587,248587,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,China,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
349494,TB_rdst_num,COUNTRY,ALB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Albania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
354727,TB_rdst_num,COUNTRY,LTU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,483,483,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Lithuania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
360986,TB_rdst_num,COUNTRY,MUS,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Mauritius,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
365168,TB_rdst_num,COUNTRY,BEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1292,1292,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Benin,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
371438,TB_rdst_num,COUNTRY,GRD,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Grenada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
372125,TB_rdst_num,COUNTRY,LAO,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,138,138,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Lao People's Democratic Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
377463,TB_rdst_num,COUNTRY,JOR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Jordan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
382107,TB_rdst_num,COUNTRY,FIN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,121,121,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Finland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
383536,TB_rdst_num,COUNTRY,ITA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1905,1905,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Italy,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
393653,TB_rdst_num,COUNTRY,COK,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cook Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
399708,TB_rdst_num,COUNTRY,COG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,74,74,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
415555,TB_rdst_num,COUNTRY,CUB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,319,319,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Cuba,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
420643,TB_rdst_num,COUNTRY,PRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,17,17,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Puerto Rico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
427113,TB_rdst_num,COUNTRY,EGY,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,326,326,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Egypt,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
441588,TB_rdst_num,COUNTRY,BGR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,36,36,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bulgaria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
445750,TB_rdst_num,COUNTRY,SRB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,30,30,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Serbia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
447366,TB_rdst_num,COUNTRY,GEO,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1442,1442,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Georgia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
450125,TB_rdst_num,COUNTRY,BMU,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bermuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
456065,TB_rdst_num,COUNTRY,ITA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,15,15,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Italy,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
465942,TB_rdst_num,COUNTRY,TJK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1862,1862,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Tajikistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
489084,TB_rdst_num,COUNTRY,KWT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Kuwait,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
504310,TB_rdst_num,COUNTRY,VNM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,39 603,39603,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Viet Nam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
508663,TB_rdst_num,COUNTRY,GNB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Guinea-Bissau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
520388,TB_rdst_num,COUNTRY,CUW,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,CuraÃ§ao,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
520793,TB_rdst_num,COUNTRY,AUS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,22,22,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Australia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
580269,TB_rdst_num,COUNTRY,USA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,5189,5189,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United States of America,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
582892,TB_rdst_num,COUNTRY,PSE,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,"occupied Palestinian territory, including east Jerusalem",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
587402,TB_rdst_num,COUNTRY,BMU,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bermuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
590673,TB_rdst_num,COUNTRY,SUR,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Suriname,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
599417,TB_rdst_num,COUNTRY,NIU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Niue,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
618522,TB_rdst_num,COUNTRY,ALB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,26,26,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Albania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
642582,TB_rdst_num,COUNTRY,MAC,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,193,193,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,"China, Macao Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
647420,TB_rdst_num,COUNTRY,LTU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,751,751,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Lithuania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
662906,TB_rdst_num,COUNTRY,SGP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,86,86,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Singapore,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
674108,TB_rdst_num,COUNTRY,COK,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cook Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
689088,TB_rdst_num,COUNTRY,MRT,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,59,59,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Mauritania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
690452,TB_rdst_num,COUNTRY,HTI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1390,1390,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Haiti,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
692566,TB_rdst_num,COUNTRY,TLS,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,20,20,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Timor-Leste,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
703224,TB_rdst_num,COUNTRY,SXM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Sint Maarten (Dutch part),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
709838,TB_rdst_num,COUNTRY,CZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,223,223,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Czechia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
719187,TB_rdst_num,COUNTRY,KWT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,401,401,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Kuwait,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
720912,TB_rdst_num,COUNTRY,UGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1898,1898,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uganda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
723736,TB_rdst_num,COUNTRY,ETH,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,2513,2513,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ethiopia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
727830,TB_rdst_num,COUNTRY,LKA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,362,362,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sri Lanka,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
733464,TB_rdst_num,COUNTRY,MDA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,367,367,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Republic of Moldova,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
746010,TB_rdst_num,COUNTRY,TON,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Tonga,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
747023,TB_rdst_num,COUNTRY,TCA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Turks and Caicos Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
759334,TB_rdst_num,COUNTRY,DJI,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Djibouti,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
765806,TB_rdst_num,COUNTRY,LTU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,218,218,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Lithuania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
768679,TB_rdst_num,COUNTRY,MEX,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,80,80,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mexico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
771581,TB_rdst_num,COUNTRY,PAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,56,56,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Panama,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
775856,TB_rdst_num,COUNTRY,LBY,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,732,732,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Libya,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
778761,TB_rdst_num,COUNTRY,CAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,37,37,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Central African Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
779118,TB_rdst_num,COUNTRY,NIU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Niue,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
781965,TB_rdst_num,COUNTRY,ITA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1391,1391,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Italy,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
785656,TB_rdst_num,COUNTRY,HTI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,714,714,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Haiti,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
806142,TB_rdst_num,COUNTRY,BIH,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,381,381,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bosnia and Herzegovina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
821581,TB_rdst_num,COUNTRY,CUB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,67,67,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cuba,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
830457,TB_rdst_num,COUNTRY,VUT,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Vanuatu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
838179,TB_rdst_num,COUNTRY,ECU,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1113,1113,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Ecuador,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
866110,TB_rdst_num,COUNTRY,AUS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,708,708,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Australia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
866604,TB_rdst_num,COUNTRY,NOR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,9,9,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Norway,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
866649,TB_rdst_num,COUNTRY,RUS,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,18 831,18831,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Russian Federation,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
871740,TB_rdst_num,COUNTRY,BEL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,437,437,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Belgium,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
874846,TB_rdst_num,COUNTRY,MRT,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mauritania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
889553,TB_rdst_num,COUNTRY,SOM,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,5222,5222,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Somalia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
891461,TB_rdst_num,COUNTRY,BHS,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bahamas,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
895755,TB_rdst_num,COUNTRY,ETH,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,3243,3243,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Ethiopia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
897890,TB_rdst_num,COUNTRY,RUS,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,24 287,24287,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Russian Federation,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
901099,TB_rdst_num,COUNTRY,SEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,3191,3191,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Senegal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
918315,TB_rdst_num,COUNTRY,GNB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,31,31,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Guinea-Bissau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
922906,TB_rdst_num,COUNTRY,MLT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,34,34,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Malta,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
924740,TB_rdst_num,COUNTRY,AGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,29 679,29679,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Angola,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
938670,TB_rdst_num,COUNTRY,KIR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,158,158,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Kiribati,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
950164,TB_rdst_num,COUNTRY,TUV,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,13,13,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Tuvalu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
956023,TB_rdst_num,COUNTRY,TUR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,3654,3654,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,TÃ¼rkiye,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
974443,TB_rdst_num,COUNTRY,GUM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Guam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
977092,TB_rdst_num,COUNTRY,CHL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1887,1887,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Chile,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
988965,TB_rdst_num,COUNTRY,EGY,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,295,295,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Egypt,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1003507,TB_rdst_num,COUNTRY,PRT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,50,50,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Portugal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1006302,TB_rdst_num,COUNTRY,KHM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,7415,7415,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cambodia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1006627,TB_rdst_num,COUNTRY,THA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,3587,3587,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Thailand,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1008812,TB_rdst_num,COUNTRY,ISL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Iceland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1014192,TB_rdst_num,COUNTRY,MNP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,24,24,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Northern Mariana Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1030663,TB_rdst_num,COUNTRY,MHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Marshall Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1033466,TB_rdst_num,COUNTRY,AUT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,15,15,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Austria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1039101,TB_rdst_num,COUNTRY,GRL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,29,29,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Greenland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1044410,TB_rdst_num,COUNTRY,SLV,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,521,521,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,El Salvador,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1047011,TB_rdst_num,COUNTRY,LBR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,59,59,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Liberia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1053220,TB_rdst_num,COUNTRY,BFA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1150,1150,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Burkina Faso,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1060790,TB_rdst_num,COUNTRY,BIH,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,36,36,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Bosnia and Herzegovina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1061967,TB_rdst_num,COUNTRY,BGD,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,38 977,38977,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bangladesh,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1063078,TB_rdst_num,COUNTRY,CIV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1135,1135,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cote d'Ivoire,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1072806,TB_rdst_num,COUNTRY,FSM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Micronesia (Federated States of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1082702,TB_rdst_num,COUNTRY,KOR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,2273,2273,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Republic of Korea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1083141,TB_rdst_num,COUNTRY,NIC,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,106,106,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Nicaragua,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1092014,TB_rdst_num,COUNTRY,GUM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Guam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1093882,TB_rdst_num,COUNTRY,ERI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,660,660,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Eritrea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1094805,TB_rdst_num,COUNTRY,MNP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Northern Mariana Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1097398,TB_rdst_num,COUNTRY,TCD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,2648,2648,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Chad,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1099151,TB_rdst_num,COUNTRY,BRN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,16,16,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Brunei Darussalam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1102665,TB_rdst_num,COUNTRY,BRB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Barbados,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1113380,TB_rdst_num,COUNTRY,PRY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,210,210,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Paraguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1123153,TB_rdst_num,COUNTRY,GRD,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Grenada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1129003,TB_rdst_num,COUNTRY,AFG,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,5443,5443,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Afghanistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1139236,TB_rdst_num,COUNTRY,MNE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Montenegro,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1144644,TB_rdst_num,COUNTRY,LBN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,286,286,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Lebanon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1145333,TB_rdst_num,COUNTRY,BHS,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,18,18,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bahamas,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1147110,TB_rdst_num,COUNTRY,FIN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,134,134,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Finland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1148163,TB_rdst_num,COUNTRY,BOL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,5085,5085,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Bolivia (Plurinational State of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1148682,TB_rdst_num,COUNTRY,CPV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cabo Verde,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1151305,TB_rdst_num,COUNTRY,MLI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,37,37,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Mali,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1154366,TB_rdst_num,COUNTRY,GIN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,4242,4242,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1156599,TB_rdst_num,COUNTRY,GRC,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,55,55,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Greece,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1160155,TB_rdst_num,COUNTRY,GNQ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,250,250,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Equatorial Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1166750,TB_rdst_num,COUNTRY,GBR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1734,1734,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1170218,TB_rdst_num,COUNTRY,JAM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Jamaica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1181957,TB_rdst_num,COUNTRY,HKG,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,2105,2105,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,"China, Hong Kong Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1187095,TB_rdst_num,COUNTRY,GRL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Greenland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1188756,TB_rdst_num,COUNTRY,SEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,906,906,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Senegal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1196541,TB_rdst_num,COUNTRY,MHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,31,31,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Marshall Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1207059,TB_rdst_num,COUNTRY,KOR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,13 814,13814,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Republic of Korea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1207301,TB_rdst_num,COUNTRY,SDN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,4063,4063,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1215583,TB_rdst_num,COUNTRY,AFG,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,2233,2233,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Afghanistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1218130,TB_rdst_num,COUNTRY,MAC,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,17,17,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,"China, Macao Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1220231,TB_rdst_num,COUNTRY,QAT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Qatar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1225297,TB_rdst_num,COUNTRY,TTO,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,12,12,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Trinidad and Tobago,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1229316,TB_rdst_num,COUNTRY,COG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1202,1202,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1234723,TB_rdst_num,COUNTRY,ROU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,1702,1702,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Romania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1237484,TB_rdst_num,COUNTRY,MLI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,308,308,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Mali,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1242452,TB_rdst_num,COUNTRY,GAB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,239,239,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Gabon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1244119,TB_rdst_num,COUNTRY,IDN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,17 138,17138,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Indonesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1246564,TB_rdst_num,COUNTRY,VUT,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,46,46,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Vanuatu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1247529,TB_rdst_num,COUNTRY,TZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,19 175,19175,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Republic of Tanzania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1268281,TB_rdst_num,COUNTRY,ZWE,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,706,706,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Zimbabwe,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1268810,TB_rdst_num,COUNTRY,PYF,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,French Polynesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1271717,TB_rdst_num,COUNTRY,SSD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,104,104,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,South Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1273226,TB_rdst_num,COUNTRY,LTU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,180,180,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Lithuania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1290400,TB_rdst_num,COUNTRY,HND,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,222,222,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Honduras,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1292075,TB_rdst_num,COUNTRY,KWT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Kuwait,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1295927,TB_rdst_num,COUNTRY,BLR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1529,1529,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belarus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1300777,TB_rdst_num,COUNTRY,BOL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,366,366,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bolivia (Plurinational State of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1307920,TB_rdst_num,COUNTRY,SWE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,10,10,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Sweden,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1311214,TB_rdst_num,COUNTRY,CYP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cyprus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1314681,TB_rdst_num,COUNTRY,SDN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,4804,4804,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1315393,TB_rdst_num,COUNTRY,UZB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,3946,3946,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Uzbekistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1324769,TB_rdst_num,COUNTRY,GMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1175,1175,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Gambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1326149,TB_rdst_num,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,United Arab Emirates,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1333403,TB_rdst_num,COUNTRY,GRC,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,263,263,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Greece,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1342133,TB_rdst_num,COUNTRY,BRN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,170,170,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Brunei Darussalam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1344209,TB_rdst_num,COUNTRY,MDV,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Maldives,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1344434,TB_rdst_num,COUNTRY,MOZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1307,1307,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Mozambique,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1351511,TB_rdst_num,COUNTRY,VNM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,6113,6113,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Viet Nam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1357617,TB_rdst_num,COUNTRY,UZB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,4439,4439,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Uzbekistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1357658,TB_rdst_num,COUNTRY,MEX,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,418,418,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Mexico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1359242,TB_rdst_num,COUNTRY,LVA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,59,59,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Latvia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1361304,TB_rdst_num,COUNTRY,NIC,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1021,1021,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Nicaragua,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1367651,TB_rdst_num,COUNTRY,BRN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,194,194,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Brunei Darussalam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1368556,TB_rdst_num,COUNTRY,BLZ,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,55,55,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belize,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1368892,TB_rdst_num,COUNTRY,TCD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,498,498,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Chad,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1369155,TB_rdst_num,COUNTRY,LCA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Saint Lucia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1369933,TB_rdst_num,COUNTRY,EST,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,20,20,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Estonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1373845,TB_rdst_num,COUNTRY,UZB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,2145,2145,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Uzbekistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1385999,TB_rdst_num,COUNTRY,ESP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,31,31,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Spain,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1388271,TB_rdst_num,COUNTRY,COD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,5854,5854,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Democratic Republic of the Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1391361,TB_rdst_num,COUNTRY,SVN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Slovenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1393719,TB_rdst_num,COUNTRY,GIN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,2279,2279,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1397141,TB_rdst_num,COUNTRY,BEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,205,205,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Benin,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1411050,TB_rdst_num,COUNTRY,IND,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,128 236,128236,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,India,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1436101,TB_rdst_num,COUNTRY,AFG,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,501,501,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Afghanistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1442743,TB_rdst_num,COUNTRY,NER,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,529,529,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Niger,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1445414,TB_rdst_num,COUNTRY,ZMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,397,397,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Zambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1446044,TB_rdst_num,COUNTRY,SSD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,54,54,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,South Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1456944,TB_rdst_num,COUNTRY,YEM,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,64,64,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Yemen,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1462703,TB_rdst_num,COUNTRY,BLZ,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Belize,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1472412,TB_rdst_num,COUNTRY,JOR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,83,83,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Jordan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1475245,TB_rdst_num,COUNTRY,TGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,214,214,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Togo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1475575,TB_rdst_num,COUNTRY,PLW,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,12,12,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Palau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1480196,TB_rdst_num,COUNTRY,SUR,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,97,97,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Suriname,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1485845,TB_rdst_num,COUNTRY,USA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,5329,5329,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,United States of America,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1488215,TB_rdst_num,COUNTRY,BDI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,314,314,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Burundi,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1489810,TB_rdst_num,COUNTRY,HKG,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,194,194,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,"China, Hong Kong Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1494728,TB_rdst_num,COUNTRY,BGR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,50,50,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Bulgaria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1508603,TB_rdst_num,COUNTRY,MAR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1750,1750,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Morocco,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1512810,TB_rdst_num,COUNTRY,CZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,10,10,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Czechia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1517039,TB_rdst_num,COUNTRY,MLI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,12,12,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Mali,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1521477,TB_rdst_num,COUNTRY,NER,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,538,538,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Niger,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1526231,TB_rdst_num,COUNTRY,LSO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,2279,2279,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Lesotho,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1535842,TB_rdst_num,COUNTRY,BHR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,82,82,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bahrain,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1541731,TB_rdst_num,COUNTRY,KEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,28 316,28316,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Kenya,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1545417,TB_rdst_num,COUNTRY,MAC,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,23,23,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,"China, Macao Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1558582,TB_rdst_num,COUNTRY,IND,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,152 177,152177,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,India,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1560741,TB_rdst_num,COUNTRY,BFA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,3042,3042,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Burkina Faso,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1569068,TB_rdst_num,COUNTRY,BMU,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bermuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1572194,TB_rdst_num,COUNTRY,YEM,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,460,460,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Yemen,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1577311,TB_rdst_num,COUNTRY,TGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,650,650,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Togo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1580115,TB_rdst_num,COUNTRY,ISR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,154,154,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Israel,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1588266,TB_rdst_num,COUNTRY,TZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,1047,1047,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Republic of Tanzania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1588570,TB_rdst_num,COUNTRY,LUX,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,21,21,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Luxembourg,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1594146,TB_rdst_num,COUNTRY,DEU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,140,140,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Germany,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1601537,TB_rdst_num,COUNTRY,SDN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,561,561,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1603189,TB_rdst_num,COUNTRY,TUN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,70,70,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Tunisia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1613236,TB_rdst_num,COUNTRY,JOR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,62,62,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Jordan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1620362,TB_rdst_num,COUNTRY,NRU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Nauru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1620982,TB_rdst_num,COUNTRY,DEU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1440,1440,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Germany,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1624466,TB_rdst_num,COUNTRY,KEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,3246,3246,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Kenya,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1626357,TB_rdst_num,COUNTRY,SWZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1598,1598,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Eswatini,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1627306,TB_rdst_num,COUNTRY,NER,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,525,525,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Niger,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1633977,TB_rdst_num,COUNTRY,CYP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,29,29,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Cyprus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1663657,TB_rdst_num,COUNTRY,MNG,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,375,375,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Mongolia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1664649,TB_rdst_num,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,125 823,125823,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Pakistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1666385,TB_rdst_num,COUNTRY,SWE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,173,173,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Sweden,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1672263,TB_rdst_num,COUNTRY,CHL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,101,101,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Chile,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1676142,TB_rdst_num,COUNTRY,VUT,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Vanuatu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1681776,TB_rdst_num,COUNTRY,FJI,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,138,138,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Fiji,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1683151,TB_rdst_num,COUNTRY,PRY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,871,871,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Paraguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1684429,TB_rdst_num,COUNTRY,PRK,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Democratic People's Republic of Korea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1694360,TB_rdst_num,COUNTRY,CIV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,6932,6932,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cote d'Ivoire,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1697427,TB_rdst_num,COUNTRY,GRD,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Grenada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1703403,TB_rdst_num,COUNTRY,COG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,587,587,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1704107,TB_rdst_num,COUNTRY,SVN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Slovenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1704790,TB_rdst_num,COUNTRY,GAB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,807,807,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Gabon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1706982,TB_rdst_num,COUNTRY,LUX,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Luxembourg,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1720157,TB_rdst_num,COUNTRY,CAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,898,898,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Canada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1723443,TB_rdst_num,COUNTRY,HKG,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,176,176,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,"China, Hong Kong Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1729922,TB_rdst_num,COUNTRY,LCA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,9,9,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Saint Lucia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1731737,TB_rdst_num,COUNTRY,LAO,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,242,242,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Lao People's Democratic Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1739109,TB_rdst_num,COUNTRY,PAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,36,36,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Panama,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1739598,TB_rdst_num,COUNTRY,KGZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1244,1244,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Kyrgyzstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1740376,TB_rdst_num,COUNTRY,DEU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,116,116,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Germany,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1741663,TB_rdst_num,COUNTRY,BWA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,97,97,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Botswana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1747136,TB_rdst_num,COUNTRY,ROU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,5890,5890,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Romania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1771877,TB_rdst_num,COUNTRY,RUS,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,21 099,21099,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Russian Federation,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1773909,TB_rdst_num,COUNTRY,VCT,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1773973,TB_rdst_num,COUNTRY,MDG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,70,70,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Madagascar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1777147,TB_rdst_num,COUNTRY,VCT,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1789865,TB_rdst_num,COUNTRY,BMU,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bermuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1792795,TB_rdst_num,COUNTRY,TGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1805,1805,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Togo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1798247,TB_rdst_num,COUNTRY,EGY,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,306,306,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Egypt,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1801746,TB_rdst_num,COUNTRY,COD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,4682,4682,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Democratic Republic of the Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1802144,TB_rdst_num,COUNTRY,SGP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1066,1066,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Singapore,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1802437,TB_rdst_num,COUNTRY,CYP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Cyprus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1802950,TB_rdst_num,COUNTRY,DZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,146,146,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Algeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1805556,TB_rdst_num,COUNTRY,HUN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,302,302,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Hungary,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1810007,TB_rdst_num,COUNTRY,USA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,5136,5136,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United States of America,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1823391,TB_rdst_num,COUNTRY,TJK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,510,510,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Tajikistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1827439,TB_rdst_num,COUNTRY,DZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,87,87,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Algeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1828535,TB_rdst_num,COUNTRY,NPL,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,1993,1993,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Nepal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1833448,TB_rdst_num,COUNTRY,UKR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,6219,6219,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ukraine,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1836751,TB_rdst_num,COUNTRY,BLR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1032,1032,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Belarus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1837858,TB_rdst_num,COUNTRY,ZWE,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,410,410,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Zimbabwe,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1838181,TB_rdst_num,COUNTRY,MDA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,991,991,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Republic of Moldova,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1848180,TB_rdst_num,COUNTRY,POL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,3196,3196,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Poland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1879497,TB_rdst_num,COUNTRY,NIC,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,627,627,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Nicaragua,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1881561,TB_rdst_num,COUNTRY,MLI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,331,331,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Mali,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1889593,TB_rdst_num,COUNTRY,BRA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,24 394,24394,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Brazil,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1894520,TB_rdst_num,COUNTRY,BRA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,20 530,20530,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Brazil,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1894939,TB_rdst_num,COUNTRY,NER,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,389,389,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Niger,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1903803,TB_rdst_num,COUNTRY,AFG,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,642,642,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Afghanistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1905489,TB_rdst_num,COUNTRY,ISL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Iceland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1907388,TB_rdst_num,COUNTRY,CZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,15,15,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Czechia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1910328,TB_rdst_num,COUNTRY,OMN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Oman,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1916994,TB_rdst_num,COUNTRY,BGD,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,36 583,36583,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bangladesh,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1919257,TB_rdst_num,COUNTRY,KEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,33 149,33149,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Kenya,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1953177,TB_rdst_num,COUNTRY,CUW,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,8,8,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,CuraÃ§ao,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1958678,TB_rdst_num,COUNTRY,TUR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,248,248,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,TÃ¼rkiye,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1960299,TB_rdst_num,COUNTRY,MDV,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Maldives,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1961282,TB_rdst_num,COUNTRY,KIR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Kiribati,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1968377,TB_rdst_num,COUNTRY,RUS,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,20 923,20923,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Russian Federation,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1973201,TB_rdst_num,COUNTRY,BHS,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,16,16,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bahamas,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1976417,TB_rdst_num,COUNTRY,BEL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,320,320,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Belgium,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1977527,TB_rdst_num,COUNTRY,DEU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,67,67,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Germany,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1978517,TB_rdst_num,COUNTRY,RWA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,3441,3441,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Rwanda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1980579,TB_rdst_num,COUNTRY,CAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,17,17,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Central African Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1981912,TB_rdst_num,COUNTRY,WSM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,13,13,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Samoa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1982482,TB_rdst_num,COUNTRY,TTO,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,151,151,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Trinidad and Tobago,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1982586,TB_rdst_num,COUNTRY,MEX,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,2275,2275,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mexico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1987803,TB_rdst_num,COUNTRY,PLW,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,19,19,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Palau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1991297,TB_rdst_num,COUNTRY,SLB,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Solomon Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2004087,TB_rdst_num,COUNTRY,USA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,4814,4814,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,United States of America,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2018483,TB_rdst_num,COUNTRY,SWZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,143,143,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Eswatini,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2023564,TB_rdst_num,COUNTRY,CAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,168,168,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Central African Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2032109,TB_rdst_num,COUNTRY,VCT,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2043000,TB_rdst_num,COUNTRY,COG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,2015,2015,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2043596,TB_rdst_num,COUNTRY,CZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,20,20,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Czechia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2045670,TB_rdst_num,COUNTRY,BRA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,6079,6079,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Brazil,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2046494,TB_rdst_num,COUNTRY,USA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,238,238,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United States of America,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2047183,TB_rdst_num,COUNTRY,MNP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Northern Mariana Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2049269,TB_rdst_num,COUNTRY,DEU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1565,1565,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Germany,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2050137,TB_rdst_num,COUNTRY,BIH,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,24,24,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Bosnia and Herzegovina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2053359,TB_rdst_num,COUNTRY,UGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,2132,2132,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Uganda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2067736,TB_rdst_num,COUNTRY,CUB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,53,53,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Cuba,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2068364,TB_rdst_num,COUNTRY,SUR,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Suriname,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2069964,TB_rdst_num,COUNTRY,FIN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,100,100,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Finland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2076693,TB_rdst_num,COUNTRY,KNA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Saint Kitts and Nevis,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2079900,TB_rdst_num,COUNTRY,SVN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,70,70,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2084068,TB_rdst_num,COUNTRY,CHL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1510,1510,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Chile,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2089163,TB_rdst_num,COUNTRY,ISR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Israel,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2097556,TB_rdst_num,COUNTRY,MDV,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,46,46,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Maldives,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2103738,TB_rdst_num,COUNTRY,PRK,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,477,477,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Democratic People's Republic of Korea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2107091,TB_rdst_num,COUNTRY,LKA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1214,1214,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Sri Lanka,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2114227,TB_rdst_num,COUNTRY,CRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,21,21,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Costa Rica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2121924,TB_rdst_num,COUNTRY,KIR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,188,188,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Kiribati,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2126430,TB_rdst_num,COUNTRY,MAR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1666,1666,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Morocco,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2128507,TB_rdst_num,COUNTRY,MHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Marshall Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2131356,TB_rdst_num,COUNTRY,ETH,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,3118,3118,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ethiopia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2153296,TB_rdst_num,COUNTRY,NGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,4758,4758,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Nigeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2154468,TB_rdst_num,COUNTRY,BEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,236,236,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Benin,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2155815,TB_rdst_num,COUNTRY,NER,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,436,436,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Niger,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2157557,TB_rdst_num,COUNTRY,MLI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1234,1234,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Mali,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2167593,TB_rdst_num,COUNTRY,SYR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,367,367,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Syrian Arab Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2176335,TB_rdst_num,COUNTRY,KNA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Saint Kitts and Nevis,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2189242,TB_rdst_num,COUNTRY,UZB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,4929,4929,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Uzbekistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2200850,TB_rdst_num,COUNTRY,SMR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,San Marino,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2201178,TB_rdst_num,COUNTRY,BRN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,162,162,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Brunei Darussalam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2206728,TB_rdst_num,COUNTRY,DOM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,113,113,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Dominican Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2210064,TB_rdst_num,COUNTRY,BOL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,3654,3654,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bolivia (Plurinational State of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2212926,TB_rdst_num,COUNTRY,COG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2220528,TB_rdst_num,COUNTRY,SVN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,58,58,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Slovenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2221060,TB_rdst_num,COUNTRY,NCL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,New Caledonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2223688,TB_rdst_num,COUNTRY,NIU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Niue,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2245752,TB_rdst_num,COUNTRY,NGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,3783,3783,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Nigeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2245827,TB_rdst_num,COUNTRY,COG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,4095,4095,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2255005,TB_rdst_num,COUNTRY,ITA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,26,26,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Italy,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2259771,TB_rdst_num,COUNTRY,SYR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,72,72,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Syrian Arab Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2267548,TB_rdst_num,COUNTRY,YEM,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,45,45,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Yemen,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2271862,TB_rdst_num,COUNTRY,SOM,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,6304,6304,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Somalia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2272617,TB_rdst_num,COUNTRY,ZAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,19 888,19888,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,South Africa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2274059,TB_rdst_num,COUNTRY,URY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,79,79,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Uruguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2277291,TB_rdst_num,COUNTRY,SMR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,San Marino,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2279830,TB_rdst_num,COUNTRY,NRU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Nauru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2284853,TB_rdst_num,COUNTRY,IRN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,3185,3185,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Iran (Islamic Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2286275,TB_rdst_num,COUNTRY,LKA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,377,377,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Sri Lanka,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2291614,TB_rdst_num,COUNTRY,COL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,193,193,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Colombia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2298507,TB_rdst_num,COUNTRY,PHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,18 364,18364,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Philippines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2299688,TB_rdst_num,COUNTRY,MRT,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Mauritania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2312913,TB_rdst_num,COUNTRY,BFA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,3282,3282,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Burkina Faso,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2315725,TB_rdst_num,COUNTRY,IRQ,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,122,122,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Iraq,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2318578,TB_rdst_num,COUNTRY,BLR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1690,1690,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belarus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2328465,TB_rdst_num,COUNTRY,YEM,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,222,222,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Yemen,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2350399,TB_rdst_num,COUNTRY,MUS,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,105,105,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Mauritius,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2350890,TB_rdst_num,COUNTRY,OMN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Oman,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2352720,TB_rdst_num,COUNTRY,BGD,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,5507,5507,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bangladesh,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2368296,TB_rdst_num,COUNTRY,BFA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1733,1733,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Burkina Faso,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2379072,TB_rdst_num,COUNTRY,PNG,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Papua New Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2386332,TB_rdst_num,COUNTRY,DOM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1724,1724,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Dominican Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2397381,TB_rdst_num,COUNTRY,CMR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,378,378,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cameroon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2406823,TB_rdst_num,COUNTRY,YEM,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,44,44,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Yemen,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2409204,TB_rdst_num,COUNTRY,NRU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Nauru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2409293,TB_rdst_num,COUNTRY,UKR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,12 122,12122,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ukraine,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2410049,TB_rdst_num,COUNTRY,SSD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,South Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2410136,TB_rdst_num,COUNTRY,MAC,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,25,25,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,"China, Macao Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2410988,TB_rdst_num,COUNTRY,DZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,410,410,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Algeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2413938,TB_rdst_num,COUNTRY,KWT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,333,333,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Kuwait,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2427472,TB_rdst_num,COUNTRY,BGR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,156,156,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Bulgaria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2431973,TB_rdst_num,COUNTRY,BMU,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Bermuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2438449,TB_rdst_num,COUNTRY,MUS,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,110,110,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Mauritius,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2444467,TB_rdst_num,COUNTRY,SYC,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Seychelles,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2449799,TB_rdst_num,COUNTRY,MAR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,975,975,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Morocco,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2462843,TB_rdst_num,COUNTRY,SVN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,8,8,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2470800,TB_rdst_num,COUNTRY,BEL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,377,377,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Belgium,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2483921,TB_rdst_num,COUNTRY,MDV,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Maldives,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2485262,TB_rdst_num,COUNTRY,GUM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,38,38,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Guam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2486841,TB_rdst_num,COUNTRY,PHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,14 738,14738,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Philippines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2488567,TB_rdst_num,COUNTRY,BFA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,183,183,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Burkina Faso,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2493228,TB_rdst_num,COUNTRY,BGR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,207,207,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bulgaria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2503395,TB_rdst_num,COUNTRY,DMA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Dominica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2508364,TB_rdst_num,COUNTRY,CPV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,98,98,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cabo Verde,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2513082,TB_rdst_num,COUNTRY,SXM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sint Maarten (Dutch part),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2519122,TB_rdst_num,COUNTRY,UZB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,1767,1767,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Uzbekistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2519355,TB_rdst_num,COUNTRY,LCA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Saint Lucia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2520451,TB_rdst_num,COUNTRY,MRT,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mauritania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2523307,TB_rdst_num,COUNTRY,GAB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,2243,2243,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Gabon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2527618,TB_rdst_num,COUNTRY,MUS,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,5,5,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Mauritius,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2532294,TB_rdst_num,COUNTRY,URY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,476,476,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Uruguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2538092,TB_rdst_num,COUNTRY,VUT,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Vanuatu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2564783,TB_rdst_num,COUNTRY,SVN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Slovenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2571623,TB_rdst_num,COUNTRY,SGP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,84,84,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Singapore,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2578983,TB_rdst_num,COUNTRY,SWZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,77,77,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Eswatini,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2596526,TB_rdst_num,COUNTRY,RUS,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,29 081,29081,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Russian Federation,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2602726,TB_rdst_num,COUNTRY,GIN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,889,889,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2603152,TB_rdst_num,COUNTRY,ZAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,92 650,92650,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,South Africa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2609002,TB_rdst_num,COUNTRY,NOR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,81,81,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Norway,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2627944,TB_rdst_num,COUNTRY,LAO,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,3796,3796,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Lao People's Democratic Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2637131,TB_rdst_num,COUNTRY,BTN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,476,476,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Bhutan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2639234,TB_rdst_num,COUNTRY,KOR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,13 558,13558,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Republic of Korea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2640962,TB_rdst_num,COUNTRY,VCT,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2644506,TB_rdst_num,COUNTRY,ABW,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Aruba,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2648762,TB_rdst_num,COUNTRY,SYC,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,14,14,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Seychelles,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2650219,TB_rdst_num,COUNTRY,POL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,3317,3317,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Poland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2652357,TB_rdst_num,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1026,1026,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Saudi Arabia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2654305,TB_rdst_num,COUNTRY,MKD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,10,10,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,North Macedonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2660051,TB_rdst_num,COUNTRY,IRL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,9,9,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2688634,TB_rdst_num,COUNTRY,BLR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,700,700,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belarus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2708272,TB_rdst_num,COUNTRY,PER,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,1333,1333,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Peru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2709342,TB_rdst_num,COUNTRY,MOZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,13 909,13909,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mozambique,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2710933,TB_rdst_num,COUNTRY,HRV,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,16,16,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Croatia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2721104,TB_rdst_num,COUNTRY,GBR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,123,123,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2728951,TB_rdst_num,COUNTRY,ISR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Israel,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2732788,TB_rdst_num,COUNTRY,PRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Puerto Rico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2733567,TB_rdst_num,COUNTRY,SMR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,San Marino,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2740464,TB_rdst_num,COUNTRY,BHS,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bahamas,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2742537,TB_rdst_num,COUNTRY,GNQ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Equatorial Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2766794,TB_rdst_num,COUNTRY,QAT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Qatar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2767191,TB_rdst_num,COUNTRY,DNK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,16,16,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Denmark,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2777496,TB_rdst_num,COUNTRY,ATG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Antigua and Barbuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2778241,TB_rdst_num,COUNTRY,KAZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,3636,3636,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Kazakhstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2784550,TB_rdst_num,COUNTRY,ITA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,75,75,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Italy,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2792494,TB_rdst_num,COUNTRY,TCA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Turks and Caicos Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2797604,TB_rdst_num,COUNTRY,JPN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,202,202,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Japan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2798018,TB_rdst_num,COUNTRY,HTI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,104,104,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Haiti,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2802879,TB_rdst_num,COUNTRY,GUY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,73,73,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Guyana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2811913,TB_rdst_num,COUNTRY,QAT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,223,223,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Qatar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2814398,TB_rdst_num,COUNTRY,DNK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,171,171,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Denmark,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2818422,TB_rdst_num,COUNTRY,KOR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,9284,9284,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Republic of Korea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2819054,TB_rdst_num,COUNTRY,CZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,296,296,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Czechia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2821884,TB_rdst_num,COUNTRY,NAM,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,631,631,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Namibia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2823931,TB_rdst_num,COUNTRY,CYP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,33,33,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cyprus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2833302,TB_rdst_num,COUNTRY,COM,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Comoros,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2834735,TB_rdst_num,COUNTRY,DZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,137,137,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Algeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2836165,TB_rdst_num,COUNTRY,NRU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Nauru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2836355,TB_rdst_num,COUNTRY,PLW,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Palau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2837204,TB_rdst_num,COUNTRY,CYM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cayman Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2843593,TB_rdst_num,COUNTRY,ESP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,630,630,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Spain,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2847791,TB_rdst_num,COUNTRY,HKG,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,2343,2343,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,"China, Hong Kong Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2852383,TB_rdst_num,COUNTRY,AGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,176,176,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Angola,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2852561,TB_rdst_num,COUNTRY,MNP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Northern Mariana Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2852878,TB_rdst_num,COUNTRY,CRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,315,315,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Costa Rica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2853919,TB_rdst_num,COUNTRY,BFA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,341,341,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Burkina Faso,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2854188,TB_rdst_num,COUNTRY,ARG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1077,1077,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Argentina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2856201,TB_rdst_num,COUNTRY,NPL,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,192,192,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Nepal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2870813,TB_rdst_num,COUNTRY,URY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,538,538,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Uruguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2898011,TB_rdst_num,COUNTRY,BRN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,197,197,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Brunei Darussalam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2898658,TB_rdst_num,COUNTRY,FRA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,France,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2899919,TB_rdst_num,COUNTRY,BLZ,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belize,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2919862,TB_rdst_num,COUNTRY,SLB,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,8,8,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Solomon Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2920127,TB_rdst_num,COUNTRY,MUS,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mauritius,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2942220,TB_rdst_num,COUNTRY,SDN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1330,1330,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2948339,TB_rdst_num,COUNTRY,PER,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,2356,2356,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Peru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2960183,TB_rdst_num,COUNTRY,CZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,278,278,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Czechia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2964941,TB_rdst_num,COUNTRY,JAM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,37,37,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Jamaica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2975743,TB_rdst_num,COUNTRY,SWZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,953,953,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Eswatini,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2976568,TB_rdst_num,COUNTRY,MNG,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1612,1612,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mongolia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2988792,TB_rdst_num,COUNTRY,BGR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,75,75,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bulgaria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2989515,TB_rdst_num,COUNTRY,TKM,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,533,533,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Turkmenistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2995603,TB_rdst_num,COUNTRY,BEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,2647,2647,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Benin,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2995629,TB_rdst_num,COUNTRY,LTU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,855,855,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Lithuania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3005913,TB_rdst_num,COUNTRY,BEL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,22,22,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Belgium,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3007333,TB_rdst_num,COUNTRY,MAR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1114,1114,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Morocco,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3010636,TB_rdst_num,COUNTRY,SYR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,70,70,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Syrian Arab Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3011576,TB_rdst_num,COUNTRY,ASM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,American Samoa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3011671,TB_rdst_num,COUNTRY,SWZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,72,72,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Eswatini,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3017348,TB_rdst_num,COUNTRY,TCD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,7424,7424,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Chad,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3020088,TB_rdst_num,COUNTRY,JAM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,44,44,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Jamaica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3025308,TB_rdst_num,COUNTRY,IRN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1828,1828,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Iran (Islamic Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3031206,TB_rdst_num,COUNTRY,COL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,259,259,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Colombia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3038534,TB_rdst_num,COUNTRY,TGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,214,214,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Togo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3048424,TB_rdst_num,COUNTRY,DMA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Dominica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3069380,TB_rdst_num,COUNTRY,SOM,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,142,142,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Somalia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3073454,TB_rdst_num,COUNTRY,COK,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Cook Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3073504,TB_rdst_num,COUNTRY,MLT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,27,27,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Malta,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3075325,TB_rdst_num,COUNTRY,ARM,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,47,47,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Armenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3080618,TB_rdst_num,COUNTRY,GAB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,118,118,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Gabon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3081850,TB_rdst_num,COUNTRY,VEN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,148,148,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3083287,TB_rdst_num,COUNTRY,IRL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,96,96,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3088447,TB_rdst_num,COUNTRY,COK,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Cook Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3093408,TB_rdst_num,COUNTRY,MKD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,100,100,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,North Macedonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3094772,TB_rdst_num,COUNTRY,TLS,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,10,10,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Timor-Leste,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3108383,TB_rdst_num,COUNTRY,EGY,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,385,385,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Egypt,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3110732,TB_rdst_num,COUNTRY,IND,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,364 292,364292,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,India,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3112913,TB_rdst_num,COUNTRY,GTM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,108,108,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Guatemala,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3114966,TB_rdst_num,COUNTRY,FJI,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Fiji,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3116896,TB_rdst_num,COUNTRY,GHA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,850,850,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ghana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3117931,TB_rdst_num,COUNTRY,EGY,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,559,559,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Egypt,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3118618,TB_rdst_num,COUNTRY,TCD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,582,582,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Chad,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3121142,TB_rdst_num,COUNTRY,ITA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,31,31,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Italy,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3134168,TB_rdst_num,COUNTRY,URY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,41,41,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Uruguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3135225,TB_rdst_num,COUNTRY,PHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,82 547,82547,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Philippines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3151063,TB_rdst_num,COUNTRY,NGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,819,819,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Nigeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3151170,TB_rdst_num,COUNTRY,ATG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Antigua and Barbuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3151242,TB_rdst_num,COUNTRY,NLD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,287,287,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Netherlands (Kingdom of the),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3154435,TB_rdst_num,COUNTRY,LBR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,20,20,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Liberia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3156069,TB_rdst_num,COUNTRY,SGP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1032,1032,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Singapore,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3157209,TB_rdst_num,COUNTRY,IRQ,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,244,244,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Iraq,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3160932,TB_rdst_num,COUNTRY,AZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,2260,2260,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Azerbaijan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3168607,TB_rdst_num,COUNTRY,NGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,967,967,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Nigeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3170632,TB_rdst_num,COUNTRY,ZWE,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,428,428,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Zimbabwe,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3177267,TB_rdst_num,COUNTRY,AUS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,712,712,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Australia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3180998,TB_rdst_num,COUNTRY,UZB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,5249,5249,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Uzbekistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3190071,TB_rdst_num,COUNTRY,MNG,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,412,412,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mongolia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3192888,TB_rdst_num,COUNTRY,LBN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,303,303,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Lebanon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3201707,TB_rdst_num,COUNTRY,WSM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,14,14,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Samoa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3212714,TB_rdst_num,COUNTRY,KNA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Saint Kitts and Nevis,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3213911,TB_rdst_num,COUNTRY,ALB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,10,10,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Albania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3213926,TB_rdst_num,COUNTRY,ARG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,181,181,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Argentina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3214457,TB_rdst_num,COUNTRY,CAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,740,740,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Canada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3225139,TB_rdst_num,COUNTRY,GUM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,35,35,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Guam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3234186,TB_rdst_num,COUNTRY,PLW,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Palau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3240780,TB_rdst_num,COUNTRY,MHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,65,65,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Marshall Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3244597,TB_rdst_num,COUNTRY,SVK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,21,21,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Slovakia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3251996,TB_rdst_num,COUNTRY,GBR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,78,78,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3258705,TB_rdst_num,COUNTRY,AUT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,5,5,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Austria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3274240,TB_rdst_num,COUNTRY,PSE,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,"occupied Palestinian territory, including east Jerusalem",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3281374,TB_rdst_num,COUNTRY,GNB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Guinea-Bissau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3282489,TB_rdst_num,COUNTRY,CAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,50,50,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Canada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3283445,TB_rdst_num,COUNTRY,GIN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,415,415,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3286971,TB_rdst_num,COUNTRY,ATG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Antigua and Barbuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3288377,TB_rdst_num,COUNTRY,BLZ,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Belize,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3289060,TB_rdst_num,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,United Arab Emirates,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3296004,TB_rdst_num,COUNTRY,ASM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,American Samoa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3297330,TB_rdst_num,COUNTRY,CMR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,2530,2530,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Cameroon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3303405,TB_rdst_num,COUNTRY,CPV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Cabo Verde,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3330094,TB_rdst_num,COUNTRY,SLB,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,106,106,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Solomon Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3335033,TB_rdst_num,COUNTRY,BGR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,524,524,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bulgaria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3350082,TB_rdst_num,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,United Arab Emirates,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3352304,TB_rdst_num,COUNTRY,HUN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,287,287,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Hungary,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3366957,TB_rdst_num,COUNTRY,MDV,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Maldives,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3371295,TB_rdst_num,COUNTRY,TUR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,381,381,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,TÃ¼rkiye,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3372730,TB_rdst_num,COUNTRY,PRK,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,2560,2560,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Democratic People's Republic of Korea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3385004,TB_rdst_num,COUNTRY,GMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Gambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3385565,TB_rdst_num,COUNTRY,MKD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,128,128,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,North Macedonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3397660,TB_rdst_num,COUNTRY,SWE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sweden,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3402093,TB_rdst_num,COUNTRY,ISR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,103,103,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Israel,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3415688,TB_rdst_num,COUNTRY,TCD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1763,1763,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Chad,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3421199,TB_rdst_num,COUNTRY,USA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,242,242,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United States of America,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3424759,TB_rdst_num,COUNTRY,HRV,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Croatia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3429999,TB_rdst_num,COUNTRY,IND,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,148 075,148075,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,India,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3432641,TB_rdst_num,COUNTRY,MEX,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,741,741,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mexico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3432921,TB_rdst_num,COUNTRY,ARM,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,66,66,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Armenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3437588,TB_rdst_num,COUNTRY,GRD,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Grenada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3440396,TB_rdst_num,COUNTRY,VCT,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,13,13,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3467023,TB_rdst_num,COUNTRY,IRN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,83,83,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Iran (Islamic Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3482544,TB_rdst_num,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,36 136,36136,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Pakistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3485510,TB_rdst_num,COUNTRY,GEO,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,537,537,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Georgia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3488324,TB_rdst_num,COUNTRY,SWE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,234,234,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Sweden,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3488630,TB_rdst_num,COUNTRY,MMR,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,6076,6076,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Myanmar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3494781,TB_rdst_num,COUNTRY,BRB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Barbados,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3502385,TB_rdst_num,COUNTRY,CMR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,1330,1330,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cameroon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3504821,TB_rdst_num,COUNTRY,FRA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,20,20,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,France,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3505471,TB_rdst_num,COUNTRY,TUV,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Tuvalu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3505663,TB_rdst_num,COUNTRY,AZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,2690,2690,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Azerbaijan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3522808,TB_rdst_num,COUNTRY,SRB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,275,275,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Serbia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3524043,TB_rdst_num,COUNTRY,GUY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,237,237,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Guyana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3527738,TB_rdst_num,COUNTRY,KWT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,373,373,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Kuwait,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3527866,TB_rdst_num,COUNTRY,PAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,583,583,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Panama,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3540182,TB_rdst_num,COUNTRY,GUM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Guam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3540578,TB_rdst_num,COUNTRY,HRV,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Croatia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3540748,TB_rdst_num,COUNTRY,GTM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,213,213,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Guatemala,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3548366,TB_rdst_num,COUNTRY,SYC,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Seychelles,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3550114,TB_rdst_num,COUNTRY,OMN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Oman,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3552460,TB_rdst_num,COUNTRY,AUS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,597,597,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Australia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3565082,TB_rdst_num,COUNTRY,MWI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,313,313,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Malawi,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3566391,TB_rdst_num,COUNTRY,SEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,4750,4750,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Senegal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3572686,TB_rdst_num,COUNTRY,HKG,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,205,205,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,"China, Hong Kong Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3575364,TB_rdst_num,COUNTRY,PRY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,373,373,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Paraguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3583007,TB_rdst_num,COUNTRY,WLF,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Wallis and Futuna Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3583095,TB_rdst_num,COUNTRY,KEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,3647,3647,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Kenya,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3583666,TB_rdst_num,COUNTRY,STP,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sao Tome and Principe,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3593288,TB_rdst_num,COUNTRY,MDA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1342,1342,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Republic of Moldova,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3598857,TB_rdst_num,COUNTRY,ROU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,6102,6102,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Romania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3612033,TB_rdst_num,COUNTRY,SLB,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Solomon Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3614983,TB_rdst_num,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Arab Emirates,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3624902,TB_rdst_num,COUNTRY,VNM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,7193,7193,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Viet Nam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3630505,TB_rdst_num,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,806,806,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Saudi Arabia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3631553,TB_rdst_num,COUNTRY,PYF,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,French Polynesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3634007,TB_rdst_num,COUNTRY,LKA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,356,356,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Sri Lanka,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3634564,TB_rdst_num,COUNTRY,ERI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,686,686,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Eritrea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3640999,TB_rdst_num,COUNTRY,IRN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,3035,3035,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Iran (Islamic Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3644286,TB_rdst_num,COUNTRY,MWI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,480,480,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Malawi,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3648229,TB_rdst_num,COUNTRY,GTM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1795,1795,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Guatemala,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3652954,TB_rdst_num,COUNTRY,NPL,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,12 853,12853,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Nepal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3653299,TB_rdst_num,COUNTRY,ZMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,949,949,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Zambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3654449,TB_rdst_num,COUNTRY,MDV,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,108,108,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Maldives,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3656278,TB_rdst_num,COUNTRY,OMN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Oman,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3661707,TB_rdst_num,COUNTRY,BEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,239,239,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Benin,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3671784,TB_rdst_num,COUNTRY,MLI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,59,59,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mali,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3681515,TB_rdst_num,COUNTRY,QAT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,374,374,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Qatar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3682974,TB_rdst_num,COUNTRY,UKR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,8793,8793,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ukraine,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3691229,TB_rdst_num,COUNTRY,MKD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,126,126,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,North Macedonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3702028,TB_rdst_num,COUNTRY,VCT,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3702442,TB_rdst_num,COUNTRY,KOR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,10 589,10589,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Republic of Korea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3705329,TB_rdst_num,COUNTRY,MEX,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1201,1201,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Mexico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3711519,TB_rdst_num,COUNTRY,CYP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cyprus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3715095,TB_rdst_num,COUNTRY,HND,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,136,136,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Honduras,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3719928,TB_rdst_num,COUNTRY,CYP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Cyprus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3726692,TB_rdst_num,COUNTRY,NCL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,25,25,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,New Caledonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3741944,TB_rdst_num,COUNTRY,COD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,4068,4068,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Democratic Republic of the Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3742763,TB_rdst_num,COUNTRY,DNK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,128,128,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Denmark,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3744870,TB_rdst_num,COUNTRY,SLB,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,66,66,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Solomon Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3748212,TB_rdst_num,COUNTRY,STP,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Sao Tome and Principe,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3765121,TB_rdst_num,COUNTRY,CHN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,237 238,237238,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,China,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3775409,TB_rdst_num,COUNTRY,SRB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,226,226,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Serbia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3779443,TB_rdst_num,COUNTRY,TON,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Tonga,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3781354,TB_rdst_num,COUNTRY,QAT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,335,335,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Qatar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3783153,TB_rdst_num,COUNTRY,IRL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3788219,TB_rdst_num,COUNTRY,MDV,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,43,43,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Maldives,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3794069,TB_rdst_num,COUNTRY,BGR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,18,18,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Bulgaria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3795565,TB_rdst_num,COUNTRY,IRQ,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1339,1339,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Iraq,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3815663,TB_rdst_num,COUNTRY,CHN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,36 433,36433,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,China,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3820317,TB_rdst_num,COUNTRY,JOR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,94,94,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Jordan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3834443,TB_rdst_num,COUNTRY,MWI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,527,527,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Malawi,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3834924,TB_rdst_num,COUNTRY,IRQ,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,143,143,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Iraq,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3842613,TB_rdst_num,COUNTRY,MLT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Malta,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3843911,TB_rdst_num,COUNTRY,MHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,20,20,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Marshall Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3851074,TB_rdst_num,COUNTRY,GNB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1212,1212,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Guinea-Bissau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3851951,TB_rdst_num,COUNTRY,PRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,30,30,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Puerto Rico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3853351,TB_rdst_num,COUNTRY,LTU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,268,268,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Lithuania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3866224,TB_rdst_num,COUNTRY,KWT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,333,333,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Kuwait,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3875194,TB_rdst_num,COUNTRY,FRA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,237,237,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,France,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3876188,TB_rdst_num,COUNTRY,MRT,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Mauritania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3877249,TB_rdst_num,COUNTRY,GHA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,624,624,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Ghana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3897413,TB_rdst_num,COUNTRY,MUS,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,83,83,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Mauritius,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3900184,TB_rdst_num,COUNTRY,MDA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,602,602,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Republic of Moldova,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3900572,TB_rdst_num,COUNTRY,MOZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,1117,1117,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mozambique,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3901330,TB_rdst_num,COUNTRY,MLT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,37,37,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Malta,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3907242,TB_rdst_num,COUNTRY,BOL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,3935,3935,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bolivia (Plurinational State of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3912276,TB_rdst_num,COUNTRY,PRK,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Democratic People's Republic of Korea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3922441,TB_rdst_num,COUNTRY,NIC,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,91,91,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Nicaragua,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3925941,TB_rdst_num,COUNTRY,BHR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Bahrain,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3926597,TB_rdst_num,COUNTRY,MRT,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,41,41,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Mauritania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3940584,TB_rdst_num,COUNTRY,PHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,26 602,26602,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Philippines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3951290,TB_rdst_num,COUNTRY,VEN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,107,107,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3951317,TB_rdst_num,COUNTRY,GAB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,536,536,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Gabon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3957199,TB_rdst_num,COUNTRY,DZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,284,284,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Algeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3958206,TB_rdst_num,COUNTRY,ISL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Iceland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3969415,TB_rdst_num,COUNTRY,LSO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,3431,3431,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Lesotho,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3969477,TB_rdst_num,COUNTRY,VNM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,46 408,46408,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Viet Nam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3977357,TB_rdst_num,COUNTRY,SUR,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,8,8,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Suriname,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3981923,TB_rdst_num,COUNTRY,FSM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,45,45,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Micronesia (Federated States of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3983156,TB_rdst_num,COUNTRY,CHL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,160,160,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Chile,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3984682,TB_rdst_num,COUNTRY,MEX,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,212,212,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Mexico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3998610,TB_rdst_num,COUNTRY,BHS,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,19,19,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Bahamas,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4000393,TB_rdst_num,COUNTRY,TJK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1683,1683,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Tajikistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4002761,TB_rdst_num,COUNTRY,ERI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,76,76,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Eritrea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4003056,TB_rdst_num,COUNTRY,GRC,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,16,16,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Greece,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4009696,TB_rdst_num,COUNTRY,ARM,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,250,250,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Armenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4028477,TB_rdst_num,COUNTRY,GIN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,452,452,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4034165,TB_rdst_num,COUNTRY,HTI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,108,108,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Haiti,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4040208,TB_rdst_num,COUNTRY,GEO,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,433,433,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Georgia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4046387,TB_rdst_num,COUNTRY,CPV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,9,9,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cabo Verde,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4053079,TB_rdst_num,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1561,1561,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Saudi Arabia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4059825,TB_rdst_num,COUNTRY,JPN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,6295,6295,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Japan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4062542,TB_rdst_num,COUNTRY,SLV,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,108,108,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,El Salvador,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4082766,TB_rdst_num,COUNTRY,GRD,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Grenada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4086470,TB_rdst_num,COUNTRY,MYS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,754,754,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Malaysia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4097248,TB_rdst_num,COUNTRY,MKD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,North Macedonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4098056,TB_rdst_num,COUNTRY,PER,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,13 424,13424,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Peru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4101570,TB_rdst_num,COUNTRY,OMN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,299,299,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Oman,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4104192,TB_rdst_num,COUNTRY,ITA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1744,1744,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Italy,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4107720,TB_rdst_num,COUNTRY,GBR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,2011,2011,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4118429,TB_rdst_num,COUNTRY,EST,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,74,74,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Estonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4121863,TB_rdst_num,COUNTRY,BLZ,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,46,46,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Belize,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4142160,TB_rdst_num,COUNTRY,PRY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1639,1639,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Paraguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4145730,TB_rdst_num,COUNTRY,ZMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,15 106,15106,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Zambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4145764,TB_rdst_num,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,104,104,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Saudi Arabia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4149230,TB_rdst_num,COUNTRY,TGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,124,124,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Togo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4151102,TB_rdst_num,COUNTRY,DJI,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,93,93,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Djibouti,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4159665,TB_rdst_num,COUNTRY,CUB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,19,19,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Cuba,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4164267,TB_rdst_num,COUNTRY,YEM,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,119,119,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Yemen,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4165092,TB_rdst_num,COUNTRY,PRT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,809,809,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Portugal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4176395,TB_rdst_num,COUNTRY,BTN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,434,434,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bhutan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4176888,TB_rdst_num,COUNTRY,CYM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cayman Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4176984,TB_rdst_num,COUNTRY,TCD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,41,41,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Chad,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4186272,TB_rdst_num,COUNTRY,POL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,401,401,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Poland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4191936,TB_rdst_num,COUNTRY,ITA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1706,1706,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Italy,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4192381,TB_rdst_num,COUNTRY,QAT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,411,411,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Qatar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4194836,TB_rdst_num,COUNTRY,GNB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,17,17,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Guinea-Bissau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4215216,TB_rdst_num,COUNTRY,GIN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1121,1121,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4219131,TB_rdst_num,COUNTRY,COK,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cook Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4223868,TB_rdst_num,COUNTRY,GTM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,138,138,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Guatemala,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4233321,TB_rdst_num,COUNTRY,TLS,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Timor-Leste,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4240798,TB_rdst_num,COUNTRY,NGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,4818,4818,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Nigeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4244331,TB_rdst_num,COUNTRY,DJI,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,640,640,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Djibouti,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4253117,TB_rdst_num,COUNTRY,EST,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,21,21,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Estonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4253155,TB_rdst_num,COUNTRY,NPL,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,310,310,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Nepal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4255602,TB_rdst_num,COUNTRY,PSE,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,"occupied Palestinian territory, including east Jerusalem",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4256318,TB_rdst_num,COUNTRY,AGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1095,1095,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Angola,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4266470,TB_rdst_num,COUNTRY,PRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,14,14,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Puerto Rico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4268503,TB_rdst_num,COUNTRY,OMN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,174,174,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Oman,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4269502,TB_rdst_num,COUNTRY,SSD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,12,12,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,South Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4271002,TB_rdst_num,COUNTRY,CHL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1772,1772,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Chile,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4280305,TB_rdst_num,COUNTRY,PER,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,14 261,14261,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Peru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4281207,TB_rdst_num,COUNTRY,NIC,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1262,1262,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Nicaragua,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4284978,TB_rdst_num,COUNTRY,WSM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Samoa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4286486,TB_rdst_num,COUNTRY,KIR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Kiribati,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4290585,TB_rdst_num,COUNTRY,DNK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,12,12,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Denmark,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4294305,TB_rdst_num,COUNTRY,BLZ,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,54,54,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Belize,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4296072,TB_rdst_num,COUNTRY,TGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,87,87,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Togo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4298501,TB_rdst_num,COUNTRY,BDI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,33,33,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Burundi,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4304346,TB_rdst_num,COUNTRY,ZMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,751,751,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Zambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4305674,TB_rdst_num,COUNTRY,TTO,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,67,67,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Trinidad and Tobago,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4317576,TB_rdst_num,COUNTRY,SWZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1754,1754,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Eswatini,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4320903,TB_rdst_num,COUNTRY,CAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,852,852,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Canada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4321803,TB_rdst_num,COUNTRY,SWZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,290,290,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Eswatini,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4322191,TB_rdst_num,COUNTRY,GTM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,851,851,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Guatemala,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4339924,TB_rdst_num,COUNTRY,MDG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,4142,4142,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Madagascar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4347053,TB_rdst_num,COUNTRY,COL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1776,1776,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Colombia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4352987,TB_rdst_num,COUNTRY,GTM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,682,682,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Guatemala,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4360270,TB_rdst_num,COUNTRY,SSD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,115,115,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,South Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4374057,TB_rdst_num,COUNTRY,CRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,122,122,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Costa Rica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4376481,TB_rdst_num,COUNTRY,VNM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,30 599,30599,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Viet Nam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4381698,TB_rdst_num,COUNTRY,MWI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,3039,3039,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Malawi,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4391310,TB_rdst_num,COUNTRY,JOR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,110,110,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Jordan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4391909,TB_rdst_num,COUNTRY,MWI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,2729,2729,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Malawi,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4396760,TB_rdst_num,COUNTRY,ARM,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,209,209,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Armenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4396992,TB_rdst_num,COUNTRY,KNA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Saint Kitts and Nevis,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4399454,TB_rdst_num,COUNTRY,UGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,29 900,29900,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Uganda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4402470,TB_rdst_num,COUNTRY,MCO,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Monaco,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4407295,TB_rdst_num,COUNTRY,LAO,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1952,1952,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Lao People's Democratic Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4410286,TB_rdst_num,COUNTRY,TUV,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,15,15,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Tuvalu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4425411,TB_rdst_num,COUNTRY,FRA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,18,18,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,France,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4435434,TB_rdst_num,COUNTRY,RWA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,299,299,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Rwanda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4449149,TB_rdst_num,COUNTRY,ATG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Antigua and Barbuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4450589,TB_rdst_num,COUNTRY,PRY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,166,166,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Paraguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4455728,TB_rdst_num,COUNTRY,GTM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,2022,2022,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Guatemala,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4479962,TB_rdst_num,COUNTRY,KEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,3553,3553,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Kenya,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4492296,TB_rdst_num,COUNTRY,LBR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,17,17,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Liberia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4492762,TB_rdst_num,COUNTRY,KNA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Saint Kitts and Nevis,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4510716,TB_rdst_num,COUNTRY,PRT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,601,601,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Portugal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4510892,TB_rdst_num,COUNTRY,AFG,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,10 255,10255,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Afghanistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4523709,TB_rdst_num,COUNTRY,AUS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,735,735,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Australia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4528971,TB_rdst_num,COUNTRY,OMN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Oman,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4531275,TB_rdst_num,COUNTRY,SLV,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,521,521,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,El Salvador,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4533821,TB_rdst_num,COUNTRY,UGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,15 644,15644,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Uganda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4537384,TB_rdst_num,COUNTRY,ZAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,4103,4103,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,South Africa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4544249,TB_rdst_num,COUNTRY,HUN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,156,156,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Hungary,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4550437,TB_rdst_num,COUNTRY,MNE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,62,62,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Montenegro,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4554727,TB_rdst_num,COUNTRY,ROU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1245,1245,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Romania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4557447,TB_rdst_num,COUNTRY,LCA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Saint Lucia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4558510,TB_rdst_num,COUNTRY,PAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,408,408,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Panama,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4559257,TB_rdst_num,COUNTRY,NCL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,15,15,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,New Caledonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4565080,TB_rdst_num,COUNTRY,RWA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,3480,3480,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Rwanda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4570582,TB_rdst_num,COUNTRY,IRL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,66,66,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4577548,TB_rdst_num,COUNTRY,TZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,1090,1090,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,United Republic of Tanzania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4588958,TB_rdst_num,COUNTRY,KNA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Saint Kitts and Nevis,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4592406,TB_rdst_num,COUNTRY,PAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,44,44,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Panama,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4595180,TB_rdst_num,COUNTRY,HND,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,80,80,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Honduras,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4602257,TB_rdst_num,COUNTRY,TUN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,909,909,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Tunisia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4607829,TB_rdst_num,COUNTRY,ESP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,60,60,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Spain,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4625429,TB_rdst_num,COUNTRY,LUX,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Luxembourg,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4627684,TB_rdst_num,COUNTRY,DEU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,102,102,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Germany,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4649625,TB_rdst_num,COUNTRY,TUN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,30,30,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Tunisia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4659682,TB_rdst_num,COUNTRY,SLV,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,59,59,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,El Salvador,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4664734,TB_rdst_num,COUNTRY,GMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,45,45,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Gambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4668128,TB_rdst_num,COUNTRY,LCA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Saint Lucia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4668953,TB_rdst_num,COUNTRY,LKA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1234,1234,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sri Lanka,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4674191,TB_rdst_num,COUNTRY,COL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,2080,2080,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Colombia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4675145,TB_rdst_num,COUNTRY,ZAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,116 617,116617,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,South Africa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4680806,TB_rdst_num,COUNTRY,BGD,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,42 461,42461,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Bangladesh,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4682211,TB_rdst_num,COUNTRY,FIN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,87,87,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Finland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4691018,TB_rdst_num,COUNTRY,VEN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,281,281,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4695411,TB_rdst_num,COUNTRY,MKD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,14,14,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,North Macedonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4695519,TB_rdst_num,COUNTRY,CHL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1577,1577,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Chile,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4698283,TB_rdst_num,COUNTRY,BDI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,241,241,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Burundi,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4703366,TB_rdst_num,COUNTRY,IRL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4704087,TB_rdst_num,COUNTRY,GRC,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Greece,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4711172,TB_rdst_num,COUNTRY,CAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,62,62,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Canada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4717713,TB_rdst_num,COUNTRY,SGP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1122,1122,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Singapore,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4725222,TB_rdst_num,COUNTRY,VUT,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Vanuatu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4725777,TB_rdst_num,COUNTRY,IRN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,376,376,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Iran (Islamic Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4728330,TB_rdst_num,COUNTRY,STP,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sao Tome and Principe,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4733603,TB_rdst_num,COUNTRY,FJI,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,9,9,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Fiji,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4772872,TB_rdst_num,COUNTRY,LCA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Saint Lucia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4774571,TB_rdst_num,COUNTRY,MWI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,298,298,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malawi,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4777732,TB_rdst_num,COUNTRY,BHR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bahrain,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4789600,TB_rdst_num,COUNTRY,MUS,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Mauritius,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4790202,TB_rdst_num,COUNTRY,PRY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,768,768,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Paraguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4811748,TB_rdst_num,COUNTRY,MAC,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,224,224,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,"China, Macao Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4813896,TB_rdst_num,COUNTRY,GNQ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,87,87,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Equatorial Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4847601,TB_rdst_num,COUNTRY,BEL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,427,427,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belgium,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4851974,TB_rdst_num,COUNTRY,BOL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1191,1191,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bolivia (Plurinational State of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4851998,TB_rdst_num,COUNTRY,LUX,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,18,18,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Luxembourg,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4852598,TB_rdst_num,COUNTRY,ATG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Antigua and Barbuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4855122,TB_rdst_num,COUNTRY,RWA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,2662,2662,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Rwanda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4859404,TB_rdst_num,COUNTRY,VCT,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4861581,TB_rdst_num,COUNTRY,MLT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malta,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4864026,TB_rdst_num,COUNTRY,PNG,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Papua New Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4868208,TB_rdst_num,COUNTRY,TUR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,4914,4914,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,TÃ¼rkiye,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4896355,TB_rdst_num,COUNTRY,THA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,3724,3724,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Thailand,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4901734,TB_rdst_num,COUNTRY,AFG,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,2889,2889,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Afghanistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4914364,TB_rdst_num,COUNTRY,LBR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,57,57,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Liberia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4921509,TB_rdst_num,COUNTRY,MDG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,612,612,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Madagascar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4929404,TB_rdst_num,COUNTRY,KGZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,2375,2375,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Kyrgyzstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4931907,TB_rdst_num,COUNTRY,ESP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,23,23,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Spain,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4937255,TB_rdst_num,COUNTRY,ATG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Antigua and Barbuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4940504,TB_rdst_num,COUNTRY,TUN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,22,22,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Tunisia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4958736,TB_rdst_num,COUNTRY,WSM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Samoa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4972954,TB_rdst_num,COUNTRY,DMA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Dominica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4979190,TB_rdst_num,COUNTRY,ISR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Israel,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4979514,TB_rdst_num,COUNTRY,GRD,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Grenada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4980285,TB_rdst_num,COUNTRY,SEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1443,1443,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Senegal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4995217,TB_rdst_num,COUNTRY,SWZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,244,244,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Eswatini,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4998970,TB_rdst_num,COUNTRY,DEU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,103,103,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Germany,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5001664,TB_rdst_num,COUNTRY,ZAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,1410,1410,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,South Africa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5008307,TB_rdst_num,COUNTRY,NCL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,New Caledonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5028114,TB_rdst_num,COUNTRY,VEN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,367,367,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5039543,TB_rdst_num,COUNTRY,ERI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,347,347,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Eritrea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5039764,TB_rdst_num,COUNTRY,ARM,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,108,108,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Armenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5045039,TB_rdst_num,COUNTRY,NAM,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,2582,2582,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Namibia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5045341,TB_rdst_num,COUNTRY,GNQ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,119,119,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Equatorial Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5061994,TB_rdst_num,COUNTRY,SWZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1860,1860,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Eswatini,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5063946,TB_rdst_num,COUNTRY,SVN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,85,85,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5064341,TB_rdst_num,COUNTRY,MLT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,27,27,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Malta,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5066515,TB_rdst_num,COUNTRY,LCA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,5,5,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Saint Lucia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5069371,TB_rdst_num,COUNTRY,DEU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1763,1763,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Germany,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5075227,TB_rdst_num,COUNTRY,NIU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Niue,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5078117,TB_rdst_num,COUNTRY,MLI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,2412,2412,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mali,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5080886,TB_rdst_num,COUNTRY,GAB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,285,285,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Gabon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5082550,TB_rdst_num,COUNTRY,LBY,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Libya,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5082557,TB_rdst_num,COUNTRY,MOZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,17 227,17227,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Mozambique,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5099646,TB_rdst_num,COUNTRY,TCD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,763,763,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Chad,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5101396,TB_rdst_num,COUNTRY,CMR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1061,1061,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cameroon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5108717,TB_rdst_num,COUNTRY,THA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,18 630,18630,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Thailand,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5115434,TB_rdst_num,COUNTRY,GNB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,45,45,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Guinea-Bissau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5131545,TB_rdst_num,COUNTRY,PSE,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,13,13,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,"occupied Palestinian territory, including east Jerusalem",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5136702,TB_rdst_num,COUNTRY,TZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1115,1115,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Republic of Tanzania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5146477,TB_rdst_num,COUNTRY,BIH,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,208,208,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bosnia and Herzegovina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5162612,TB_rdst_num,COUNTRY,IRQ,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,301,301,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Iraq,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5163116,TB_rdst_num,COUNTRY,BTN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,349,349,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bhutan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5171720,TB_rdst_num,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,54,54,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Saudi Arabia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5187599,TB_rdst_num,COUNTRY,HRV,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,10,10,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Croatia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5189946,TB_rdst_num,COUNTRY,MDV,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,58,58,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Maldives,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5198904,TB_rdst_num,COUNTRY,BEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,980,980,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Benin,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5204818,TB_rdst_num,COUNTRY,LKA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,2156,2156,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sri Lanka,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5209731,TB_rdst_num,COUNTRY,ZMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,15 400,15400,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Zambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5213848,TB_rdst_num,COUNTRY,NPL,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1042,1042,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Nepal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5237499,TB_rdst_num,COUNTRY,NIU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Niue,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5258173,TB_rdst_num,COUNTRY,SEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,963,963,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Senegal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5263347,TB_rdst_num,COUNTRY,RUS,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,26 189,26189,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Russian Federation,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5279332,TB_rdst_num,COUNTRY,IDN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,10 487,10487,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Indonesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5286157,TB_rdst_num,COUNTRY,MMR,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,34 835,34835,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Myanmar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5289247,TB_rdst_num,COUNTRY,TUN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,332,332,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Tunisia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5289283,TB_rdst_num,COUNTRY,LBN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Lebanon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5304248,TB_rdst_num,COUNTRY,MNE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Montenegro,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5313453,TB_rdst_num,COUNTRY,CYM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cayman Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5320556,TB_rdst_num,COUNTRY,TZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,876,876,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,United Republic of Tanzania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5326746,TB_rdst_num,COUNTRY,TON,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Tonga,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5328120,TB_rdst_num,COUNTRY,LBR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,23,23,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Liberia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5329506,TB_rdst_num,COUNTRY,MLT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,23,23,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malta,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5336044,TB_rdst_num,COUNTRY,SVK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,79,79,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Slovakia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5347255,TB_rdst_num,COUNTRY,GEO,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1360,1360,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Georgia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5350549,TB_rdst_num,COUNTRY,UKR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,6502,6502,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ukraine,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5369983,TB_rdst_num,COUNTRY,BGD,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,47 877,47877,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bangladesh,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5373405,TB_rdst_num,COUNTRY,ROU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,1195,1195,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Romania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5377803,TB_rdst_num,COUNTRY,TUR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,3777,3777,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,TÃ¼rkiye,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5378408,TB_rdst_num,COUNTRY,BTN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,376,376,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bhutan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5389736,TB_rdst_num,COUNTRY,LTU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,465,465,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Lithuania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5391593,TB_rdst_num,COUNTRY,TTO,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,90,90,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Trinidad and Tobago,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5402023,TB_rdst_num,COUNTRY,AUT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,208,208,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Austria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5402153,TB_rdst_num,COUNTRY,CHE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,171,171,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Switzerland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5410038,TB_rdst_num,COUNTRY,BEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,259,259,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Benin,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5410493,TB_rdst_num,COUNTRY,NGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,117 519,117519,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Nigeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5419829,TB_rdst_num,COUNTRY,LSO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,475,475,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Lesotho,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5426108,TB_rdst_num,COUNTRY,SUR,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,67,67,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Suriname,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5427396,TB_rdst_num,COUNTRY,CHN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,144 192,144192,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,China,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5429449,TB_rdst_num,COUNTRY,FSM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,29,29,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Micronesia (Federated States of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5433738,TB_rdst_num,COUNTRY,CZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,16,16,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Czechia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5435254,TB_rdst_num,COUNTRY,AZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1983,1983,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Azerbaijan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5448890,TB_rdst_num,COUNTRY,MUS,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mauritius,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5453253,TB_rdst_num,COUNTRY,HKG,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,156,156,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,"China, Hong Kong Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5457658,TB_rdst_num,COUNTRY,COD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,7189,7189,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Democratic Republic of the Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5467513,TB_rdst_num,COUNTRY,PER,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,9583,9583,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Peru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5471410,TB_rdst_num,COUNTRY,MRT,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Mauritania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5473758,TB_rdst_num,COUNTRY,PLW,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Palau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5474631,TB_rdst_num,COUNTRY,ALB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Albania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5479215,TB_rdst_num,COUNTRY,LAO,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,2236,2236,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Lao People's Democratic Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5480216,TB_rdst_num,COUNTRY,IDN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,71 101,71101,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Indonesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5495457,TB_rdst_num,COUNTRY,BRA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,6187,6187,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Brazil,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5497924,TB_rdst_num,COUNTRY,BEL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,24,24,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Belgium,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5502420,TB_rdst_num,COUNTRY,CHE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Switzerland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5512758,TB_rdst_num,COUNTRY,MDG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Madagascar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5513236,TB_rdst_num,COUNTRY,ROU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,3609,3609,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Romania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5515873,TB_rdst_num,COUNTRY,KAZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,5687,5687,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Kazakhstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5516675,TB_rdst_num,COUNTRY,ZAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,18 092,18092,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,South Africa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5521070,TB_rdst_num,COUNTRY,KNA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Saint Kitts and Nevis,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5548710,TB_rdst_num,COUNTRY,HKG,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,2533,2533,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,"China, Hong Kong Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5554688,TB_rdst_num,COUNTRY,LBR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1338,1338,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Liberia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5562813,TB_rdst_num,COUNTRY,NPL,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1482,1482,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Nepal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5563297,TB_rdst_num,COUNTRY,BHR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Bahrain,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5568326,TB_rdst_num,COUNTRY,HND,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,690,690,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Honduras,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5569802,TB_rdst_num,COUNTRY,CHN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,34 990,34990,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,China,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5577409,TB_rdst_num,COUNTRY,MNP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Northern Mariana Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5578301,TB_rdst_num,COUNTRY,POL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,333,333,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Poland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5584753,TB_rdst_num,COUNTRY,SDN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,712,712,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5590624,TB_rdst_num,COUNTRY,SLV,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,120,120,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,El Salvador,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5596905,TB_rdst_num,COUNTRY,GBR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1925,1925,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5597997,TB_rdst_num,COUNTRY,CRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Costa Rica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5598393,TB_rdst_num,COUNTRY,SRB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,16,16,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Serbia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5598613,TB_rdst_num,COUNTRY,PHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,13 132,13132,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Philippines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5607407,TB_rdst_num,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,116,116,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Saudi Arabia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5610224,TB_rdst_num,COUNTRY,IRL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,8,8,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5610551,TB_rdst_num,COUNTRY,ISL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Iceland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5617171,TB_rdst_num,COUNTRY,BEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,897,897,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Benin,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5618654,TB_rdst_num,COUNTRY,GUM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,56,56,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Guam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5624691,TB_rdst_num,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,26,26,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,United Arab Emirates,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5625306,TB_rdst_num,COUNTRY,SVK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,5,5,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Slovakia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5626902,TB_rdst_num,COUNTRY,JAM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Jamaica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5629850,TB_rdst_num,COUNTRY,DZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Algeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5630835,TB_rdst_num,COUNTRY,THA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,5840,5840,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Thailand,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5632290,TB_rdst_num,COUNTRY,EST,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,123,123,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Estonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5649195,TB_rdst_num,COUNTRY,JPN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,166,166,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Japan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5650380,TB_rdst_num,COUNTRY,MYS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,10 434,10434,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Malaysia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5650624,TB_rdst_num,COUNTRY,ASM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,American Samoa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5657196,TB_rdst_num,COUNTRY,BLR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,612,612,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belarus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5658478,TB_rdst_num,COUNTRY,SDN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,6193,6193,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5658956,TB_rdst_num,COUNTRY,COK,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cook Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5663264,TB_rdst_num,COUNTRY,MAR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,906,906,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Morocco,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5663491,TB_rdst_num,COUNTRY,LUX,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Luxembourg,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5666787,TB_rdst_num,COUNTRY,MDG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Madagascar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5669489,TB_rdst_num,COUNTRY,MNP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,15,15,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Northern Mariana Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5686696,TB_rdst_num,COUNTRY,AZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1409,1409,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Azerbaijan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5686847,TB_rdst_num,COUNTRY,LSO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,2509,2509,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Lesotho,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5695074,TB_rdst_num,COUNTRY,ARG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1500,1500,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Argentina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5702446,TB_rdst_num,COUNTRY,ARG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1155,1155,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Argentina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5702804,TB_rdst_num,COUNTRY,LCA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Saint Lucia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5725478,TB_rdst_num,COUNTRY,DMA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Dominica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5726854,TB_rdst_num,COUNTRY,STP,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sao Tome and Principe,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5727162,TB_rdst_num,COUNTRY,ETH,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,15 944,15944,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Ethiopia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5727985,TB_rdst_num,COUNTRY,WSM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Samoa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5729028,TB_rdst_num,COUNTRY,SDN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,880,880,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5733651,TB_rdst_num,COUNTRY,GUY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,27,27,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Guyana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5735461,TB_rdst_num,COUNTRY,NOR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,9,9,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Norway,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5739595,TB_rdst_num,COUNTRY,CHN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,89 171,89171,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,China,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5742417,TB_rdst_num,COUNTRY,PRK,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Democratic People's Republic of Korea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5775357,TB_rdst_num,COUNTRY,BRA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,15 367,15367,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Brazil,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5776275,TB_rdst_num,COUNTRY,CUB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,290,290,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cuba,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5781445,TB_rdst_num,COUNTRY,ECU,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,503,503,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ecuador,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5782466,TB_rdst_num,COUNTRY,AUT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,14,14,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Austria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5790201,TB_rdst_num,COUNTRY,KWT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Kuwait,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5797295,TB_rdst_num,COUNTRY,ROU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,1934,1934,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Romania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5797456,TB_rdst_num,COUNTRY,JPN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,362,362,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Japan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5802914,TB_rdst_num,COUNTRY,GRD,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Grenada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5805661,TB_rdst_num,COUNTRY,USA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,242,242,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,United States of America,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5806120,TB_rdst_num,COUNTRY,HRV,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,225,225,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Croatia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5807931,TB_rdst_num,COUNTRY,SMR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,San Marino,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5808877,TB_rdst_num,COUNTRY,GRD,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Grenada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5813946,TB_rdst_num,COUNTRY,KGZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,2291,2291,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Kyrgyzstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5814426,TB_rdst_num,COUNTRY,ARG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1036,1036,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Argentina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5827680,TB_rdst_num,COUNTRY,PYF,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,30,30,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,French Polynesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5829673,TB_rdst_num,COUNTRY,TCD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,408,408,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Chad,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5833527,TB_rdst_num,COUNTRY,LAO,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,3243,3243,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Lao People's Democratic Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5833891,TB_rdst_num,COUNTRY,MYS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,587,587,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Malaysia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5840502,TB_rdst_num,COUNTRY,SSD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,42,42,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,South Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5844351,TB_rdst_num,COUNTRY,HND,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,825,825,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Honduras,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5850545,TB_rdst_num,COUNTRY,PYF,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,32,32,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,French Polynesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5852114,TB_rdst_num,COUNTRY,BTN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,9,9,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bhutan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5854011,TB_rdst_num,COUNTRY,VNM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,7520,7520,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Viet Nam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5859843,TB_rdst_num,COUNTRY,RWA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,442,442,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Rwanda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5873585,TB_rdst_num,COUNTRY,SVK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,116,116,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovakia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5886286,TB_rdst_num,COUNTRY,COL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,3134,3134,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Colombia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5888278,TB_rdst_num,COUNTRY,RUS,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,24 792,24792,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Russian Federation,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5896917,TB_rdst_num,COUNTRY,ARM,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,198,198,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Armenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5905316,TB_rdst_num,COUNTRY,DOM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,898,898,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Dominican Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5920648,TB_rdst_num,COUNTRY,AND,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Andorra,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5930136,TB_rdst_num,COUNTRY,IRL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,40,40,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5939459,TB_rdst_num,COUNTRY,NOR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,82,82,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Norway,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5947441,TB_rdst_num,COUNTRY,MDG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Madagascar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5949229,TB_rdst_num,COUNTRY,BRN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,9,9,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Brunei Darussalam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5974037,TB_rdst_num,COUNTRY,KNA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Saint Kitts and Nevis,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5974497,TB_rdst_num,COUNTRY,LBY,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,540,540,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Libya,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5979281,TB_rdst_num,COUNTRY,LTU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,134,134,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Lithuania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5995760,TB_rdst_num,COUNTRY,BDI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,31,31,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Burundi,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6002218,TB_rdst_num,COUNTRY,GNB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1934,1934,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Guinea-Bissau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6003688,TB_rdst_num,COUNTRY,MNG,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,279,279,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mongolia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6008425,TB_rdst_num,COUNTRY,AND,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Andorra,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6019938,TB_rdst_num,COUNTRY,IDN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,16 660,16660,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Indonesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6020346,TB_rdst_num,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,72 718,72718,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Pakistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6029387,TB_rdst_num,COUNTRY,MWI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,29,29,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malawi,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6038937,TB_rdst_num,COUNTRY,IDN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,97 846,97846,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Indonesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6047315,TB_rdst_num,COUNTRY,SYC,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Seychelles,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6059730,TB_rdst_num,COUNTRY,MWI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,3135,3135,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Malawi,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6061796,TB_rdst_num,COUNTRY,KWT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Kuwait,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6073046,TB_rdst_num,COUNTRY,COM,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,10,10,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Comoros,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6080893,TB_rdst_num,COUNTRY,MSR,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Montserrat,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6085376,TB_rdst_num,COUNTRY,UGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,1971,1971,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Uganda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6086022,TB_rdst_num,COUNTRY,FJI,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Fiji,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6087452,TB_rdst_num,COUNTRY,POL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,2415,2415,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Poland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6089505,TB_rdst_num,COUNTRY,PRT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,28,28,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Portugal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6091417,TB_rdst_num,COUNTRY,GNQ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,29,29,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Equatorial Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6094017,TB_rdst_num,COUNTRY,SLV,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1193,1193,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,El Salvador,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6100429,TB_rdst_num,COUNTRY,PRT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,439,439,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Portugal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6102938,TB_rdst_num,COUNTRY,STP,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Sao Tome and Principe,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6103499,TB_rdst_num,COUNTRY,CAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,139,139,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Central African Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6112257,TB_rdst_num,COUNTRY,FJI,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,5,5,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Fiji,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6114578,TB_rdst_num,COUNTRY,AUS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,26,26,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Australia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6114684,TB_rdst_num,COUNTRY,BOL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,326,326,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bolivia (Plurinational State of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6122412,TB_rdst_num,COUNTRY,MYS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,10 328,10328,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Malaysia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6138533,TB_rdst_num,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,591,591,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Saudi Arabia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6138563,TB_rdst_num,COUNTRY,JPN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,4942,4942,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Japan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6148588,TB_rdst_num,COUNTRY,GAB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,212,212,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Gabon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6159470,TB_rdst_num,COUNTRY,PRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Puerto Rico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6160657,TB_rdst_num,COUNTRY,TLS,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Timor-Leste,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6162221,TB_rdst_num,COUNTRY,SUR,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,66,66,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Suriname,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6170656,TB_rdst_num,COUNTRY,CPV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Cabo Verde,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6175495,TB_rdst_num,COUNTRY,HUN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,24,24,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Hungary,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6177388,TB_rdst_num,COUNTRY,ISR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,89,89,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Israel,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6177427,TB_rdst_num,COUNTRY,BTN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,55,55,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bhutan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6181336,TB_rdst_num,COUNTRY,CRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,5,5,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Costa Rica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6187062,TB_rdst_num,COUNTRY,JPN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,4343,4343,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Japan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6187880,TB_rdst_num,COUNTRY,ZAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,92 888,92888,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,South Africa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6193028,TB_rdst_num,COUNTRY,SSD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,329,329,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,South Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6197467,TB_rdst_num,COUNTRY,BDI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,160,160,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Burundi,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6198887,TB_rdst_num,COUNTRY,SYC,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,15,15,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Seychelles,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6199282,TB_rdst_num,COUNTRY,PLW,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,8,8,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Palau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6204762,TB_rdst_num,COUNTRY,SWE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,279,279,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sweden,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6205050,TB_rdst_num,COUNTRY,MDA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,840,840,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Republic of Moldova,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6209979,TB_rdst_num,COUNTRY,UKR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,3977,3977,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Ukraine,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6224440,TB_rdst_num,COUNTRY,GRL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,23,23,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Greenland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6238744,TB_rdst_num,COUNTRY,JOR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,76,76,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Jordan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6243415,TB_rdst_num,COUNTRY,SLB,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Solomon Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6257788,TB_rdst_num,COUNTRY,CIV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,1046,1046,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Cote d'Ivoire,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6262658,TB_rdst_num,COUNTRY,BEL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,426,426,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belgium,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6265342,TB_rdst_num,COUNTRY,YEM,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,488,488,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Yemen,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6269633,TB_rdst_num,COUNTRY,PRY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,241,241,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Paraguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6274560,TB_rdst_num,COUNTRY,NOR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,100,100,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Norway,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6291359,TB_rdst_num,COUNTRY,MOZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1577,1577,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mozambique,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6293014,TB_rdst_num,COUNTRY,IDN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,144 511,144511,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Indonesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6311805,TB_rdst_num,COUNTRY,IRN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,162,162,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Iran (Islamic Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6322848,TB_rdst_num,COUNTRY,AFG,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,10 032,10032,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Afghanistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6328963,TB_rdst_num,COUNTRY,MDG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,975,975,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Madagascar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6340140,TB_rdst_num,COUNTRY,SWE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,169,169,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Sweden,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6360177,TB_rdst_num,COUNTRY,BGD,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,6802,6802,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Bangladesh,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6367765,TB_rdst_num,COUNTRY,PRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Puerto Rico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6375406,TB_rdst_num,COUNTRY,TTO,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,10,10,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Trinidad and Tobago,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6377477,TB_rdst_num,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,57 791,57791,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Pakistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6382994,TB_rdst_num,COUNTRY,ALB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,69,69,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Albania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6388125,TB_rdst_num,COUNTRY,BIH,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,23,23,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bosnia and Herzegovina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6400308,TB_rdst_num,COUNTRY,FIN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,127,127,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Finland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6402307,TB_rdst_num,COUNTRY,PRY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,428,428,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Paraguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6402423,TB_rdst_num,COUNTRY,MKD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,136,136,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,North Macedonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6405352,TB_rdst_num,COUNTRY,VEN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,476,476,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6413316,TB_rdst_num,COUNTRY,SYC,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Seychelles,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6419996,TB_rdst_num,COUNTRY,SLV,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,42,42,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,El Salvador,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6420163,TB_rdst_num,COUNTRY,RUS,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,21 391,21391,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Russian Federation,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6427163,TB_rdst_num,COUNTRY,BMU,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Bermuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6442550,TB_rdst_num,COUNTRY,GRD,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Grenada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6452238,TB_rdst_num,COUNTRY,GUY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,118,118,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Guyana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6452367,TB_rdst_num,COUNTRY,MNE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,8,8,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Montenegro,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6455107,TB_rdst_num,COUNTRY,TUN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,30,30,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Tunisia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6455696,TB_rdst_num,COUNTRY,COD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,4792,4792,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Democratic Republic of the Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6456322,TB_rdst_num,COUNTRY,CPV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,10,10,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cabo Verde,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6460182,TB_rdst_num,COUNTRY,FSM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,24,24,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Micronesia (Federated States of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6467878,TB_rdst_num,COUNTRY,TTO,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,21,21,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Trinidad and Tobago,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6482310,TB_rdst_num,COUNTRY,MMR,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,45 169,45169,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Myanmar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6499866,TB_rdst_num,COUNTRY,URY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,512,512,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uruguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6510324,TB_rdst_num,COUNTRY,SDN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,655,655,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6512329,TB_rdst_num,COUNTRY,SWE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,21,21,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sweden,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6522084,TB_rdst_num,COUNTRY,MNG,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1106,1106,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Mongolia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6525984,TB_rdst_num,COUNTRY,IRQ,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,149,149,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Iraq,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6531801,TB_rdst_num,COUNTRY,MEX,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,4205,4205,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Mexico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6539347,TB_rdst_num,COUNTRY,TUV,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,14,14,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Tuvalu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6545081,TB_rdst_num,COUNTRY,PRK,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,3061,3061,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Democratic People's Republic of Korea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6547406,TB_rdst_num,COUNTRY,SYR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,39,39,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Syrian Arab Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6574524,TB_rdst_num,COUNTRY,MRT,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,48,48,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mauritania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6579250,TB_rdst_num,COUNTRY,GEO,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1064,1064,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Georgia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6590743,TB_rdst_num,COUNTRY,LCA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Saint Lucia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6595274,TB_rdst_num,COUNTRY,SYC,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Seychelles,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6601888,TB_rdst_num,COUNTRY,RWA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,366,366,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Rwanda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6603911,TB_rdst_num,COUNTRY,HTI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,105,105,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Haiti,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6605144,TB_rdst_num,COUNTRY,WLF,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Wallis and Futuna Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6605438,TB_rdst_num,COUNTRY,PYF,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,44,44,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,French Polynesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6616754,TB_rdst_num,COUNTRY,NER,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,141,141,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Niger,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6617743,TB_rdst_num,COUNTRY,ROU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1854,1854,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Romania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6620514,TB_rdst_num,COUNTRY,PRT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,51,51,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Portugal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6628665,TB_rdst_num,COUNTRY,OMN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,144,144,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Oman,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6630896,TB_rdst_num,COUNTRY,BHS,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Bahamas,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6635303,TB_rdst_num,COUNTRY,ARG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,585,585,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Argentina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6640794,TB_rdst_num,COUNTRY,MLT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Malta,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6642790,TB_rdst_num,COUNTRY,UGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,23 566,23566,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uganda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6654779,TB_rdst_num,COUNTRY,GBR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,128,128,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6680461,TB_rdst_num,COUNTRY,PLW,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Palau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6688171,TB_rdst_num,COUNTRY,SUR,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Suriname,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6707755,TB_rdst_num,COUNTRY,OMN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,189,189,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Oman,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6709428,TB_rdst_num,COUNTRY,UGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,28 418,28418,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Uganda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6710948,TB_rdst_num,COUNTRY,MAC,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,209,209,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,"China, Macao Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6716776,TB_rdst_num,COUNTRY,JPN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,323,323,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Japan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6723793,TB_rdst_num,COUNTRY,ALB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,13,13,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Albania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6724717,TB_rdst_num,COUNTRY,KOR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1661,1661,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Republic of Korea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6737063,TB_rdst_num,COUNTRY,SGP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1051,1051,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Singapore,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6739302,TB_rdst_num,COUNTRY,TUR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,4797,4797,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,TÃ¼rkiye,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6747901,TB_rdst_num,COUNTRY,GNQ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,58,58,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Equatorial Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6748668,TB_rdst_num,COUNTRY,ROU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,4366,4366,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Romania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6749437,TB_rdst_num,COUNTRY,PRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,29,29,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Puerto Rico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6751444,TB_rdst_num,COUNTRY,MLI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,103,103,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mali,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6759690,TB_rdst_num,COUNTRY,IRN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,263,263,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Iran (Islamic Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6762079,TB_rdst_num,COUNTRY,IRN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1387,1387,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Iran (Islamic Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6763452,TB_rdst_num,COUNTRY,AUT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,165,165,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Austria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6765695,TB_rdst_num,COUNTRY,SYR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,201,201,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Syrian Arab Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6773284,TB_rdst_num,COUNTRY,MHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Marshall Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6773694,TB_rdst_num,COUNTRY,LSO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,2209,2209,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Lesotho,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6774320,TB_rdst_num,COUNTRY,GEO,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,291,291,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Georgia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6780482,TB_rdst_num,COUNTRY,YEM,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,572,572,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Yemen,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6785035,TB_rdst_num,COUNTRY,MNG,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1242,1242,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mongolia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6788047,TB_rdst_num,COUNTRY,CZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Czechia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6792613,TB_rdst_num,COUNTRY,ASM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,American Samoa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6805883,TB_rdst_num,COUNTRY,LCA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Saint Lucia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6806136,TB_rdst_num,COUNTRY,TUR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,445,445,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,TÃ¼rkiye,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6818089,TB_rdst_num,COUNTRY,DOM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,273,273,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Dominican Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6824189,TB_rdst_num,COUNTRY,KGZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,669,669,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Kyrgyzstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6824823,TB_rdst_num,COUNTRY,PYF,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,32,32,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,French Polynesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6852867,TB_rdst_num,COUNTRY,SLB,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Solomon Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6860783,TB_rdst_num,COUNTRY,CRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Costa Rica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6866511,TB_rdst_num,COUNTRY,AFG,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,918,918,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Afghanistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6870605,TB_rdst_num,COUNTRY,LBN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,228,228,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Lebanon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6885141,TB_rdst_num,COUNTRY,AZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,2183,2183,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Azerbaijan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6909920,TB_rdst_num,COUNTRY,CMR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,3806,3806,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cameroon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6913480,TB_rdst_num,COUNTRY,SVK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,15,15,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovakia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6924391,TB_rdst_num,COUNTRY,GHA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,862,862,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ghana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6928612,TB_rdst_num,COUNTRY,LBN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,5,5,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Lebanon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6930636,TB_rdst_num,COUNTRY,QAT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Qatar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6933644,TB_rdst_num,COUNTRY,TON,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Tonga,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6937066,TB_rdst_num,COUNTRY,TLS,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,304,304,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Timor-Leste,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6937892,TB_rdst_num,COUNTRY,PHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,68 866,68866,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Philippines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6965855,TB_rdst_num,COUNTRY,BRB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Barbados,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6969661,TB_rdst_num,COUNTRY,FJI,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Fiji,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6969970,TB_rdst_num,COUNTRY,UGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,19 401,19401,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Uganda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6990475,TB_rdst_num,COUNTRY,LSO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,602,602,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Lesotho,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6993901,TB_rdst_num,COUNTRY,NLD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,244,244,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Netherlands (Kingdom of the),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6994721,TB_rdst_num,COUNTRY,ISR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Israel,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7007102,TB_rdst_num,COUNTRY,PAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,322,322,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Panama,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7024700,TB_rdst_num,COUNTRY,COM,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Comoros,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7026855,TB_rdst_num,COUNTRY,SSD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,179,179,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,South Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7037840,TB_rdst_num,COUNTRY,MNP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Northern Mariana Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7051352,TB_rdst_num,COUNTRY,AGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,10 250,10250,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Angola,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7055136,TB_rdst_num,COUNTRY,BRB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Barbados,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7058060,TB_rdst_num,COUNTRY,NER,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1127,1127,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Niger,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7069877,TB_rdst_num,COUNTRY,ECU,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,4406,4406,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Ecuador,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7078999,TB_rdst_num,COUNTRY,KAZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,2580,2580,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Kazakhstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7085229,TB_rdst_num,COUNTRY,FJI,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,148,148,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Fiji,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7101927,TB_rdst_num,COUNTRY,MLT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Malta,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7106001,TB_rdst_num,COUNTRY,GAB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,126,126,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Gabon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7107781,TB_rdst_num,COUNTRY,PRY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,267,267,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Paraguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7108158,TB_rdst_num,COUNTRY,IRL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,93,93,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7108887,TB_rdst_num,COUNTRY,TJK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,2432,2432,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Tajikistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7118664,TB_rdst_num,COUNTRY,VUT,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,41,41,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Vanuatu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7130809,TB_rdst_num,COUNTRY,CUB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,35,35,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cuba,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7133682,TB_rdst_num,COUNTRY,AUT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,192,192,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Austria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7148524,TB_rdst_num,COUNTRY,STP,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Sao Tome and Principe,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7151257,TB_rdst_num,COUNTRY,MDA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1444,1444,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Republic of Moldova,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7151268,TB_rdst_num,COUNTRY,AND,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Andorra,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7151587,TB_rdst_num,COUNTRY,CZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,308,308,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Czechia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7175510,TB_rdst_num,COUNTRY,MAR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1450,1450,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Morocco,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7175793,TB_rdst_num,COUNTRY,SLB,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Solomon Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7182091,TB_rdst_num,COUNTRY,MNE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,49,49,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Montenegro,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7188478,TB_rdst_num,COUNTRY,GHA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,8532,8532,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Ghana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7188783,TB_rdst_num,COUNTRY,CHE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,193,193,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Switzerland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7189957,TB_rdst_num,COUNTRY,ERI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,83,83,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Eritrea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7193926,TB_rdst_num,COUNTRY,KIR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,177,177,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Kiribati,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7212921,TB_rdst_num,COUNTRY,SVK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,26,26,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovakia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7217431,TB_rdst_num,COUNTRY,JOR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Jordan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7220401,TB_rdst_num,COUNTRY,ABW,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Aruba,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7225354,TB_rdst_num,COUNTRY,NIC,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,146,146,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Nicaragua,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7234606,TB_rdst_num,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,11 982,11982,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Pakistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7242822,TB_rdst_num,COUNTRY,EGY,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,402,402,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Egypt,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7254642,TB_rdst_num,COUNTRY,KEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,28 284,28284,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Kenya,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7255132,TB_rdst_num,COUNTRY,POL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,2017,2017,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Poland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7261996,TB_rdst_num,COUNTRY,BDI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1518,1518,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Burundi,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7277538,TB_rdst_num,COUNTRY,KIR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Kiribati,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7282348,TB_rdst_num,COUNTRY,MRT,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,57,57,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Mauritania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7291029,TB_rdst_num,COUNTRY,LBR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,696,696,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Liberia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7313088,TB_rdst_num,COUNTRY,CUB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,133,133,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Cuba,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7315981,TB_rdst_num,COUNTRY,TJK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,2318,2318,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Tajikistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7319066,TB_rdst_num,COUNTRY,SEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1586,1586,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Senegal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7325623,TB_rdst_num,COUNTRY,KEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,2933,2933,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Kenya,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7330531,TB_rdst_num,COUNTRY,MNE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,29,29,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Montenegro,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7336380,TB_rdst_num,COUNTRY,SVN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,78,78,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Slovenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7337311,TB_rdst_num,COUNTRY,ZMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,1855,1855,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Zambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7340247,TB_rdst_num,COUNTRY,BHS,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Bahamas,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7347333,TB_rdst_num,COUNTRY,URY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,85,85,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Uruguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7361978,TB_rdst_num,COUNTRY,LBR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1482,1482,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Liberia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7362377,TB_rdst_num,COUNTRY,AUT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,262,262,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Austria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7365227,TB_rdst_num,COUNTRY,BDI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Burundi,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7371236,TB_rdst_num,COUNTRY,FRA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,2753,2753,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,France,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7374950,TB_rdst_num,COUNTRY,SMR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,San Marino,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7380009,TB_rdst_num,COUNTRY,IDN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,125 741,125741,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Indonesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7387911,TB_rdst_num,COUNTRY,LAO,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,239,239,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Lao People's Democratic Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7395515,TB_rdst_num,COUNTRY,MEX,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,191,191,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mexico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7400401,TB_rdst_num,COUNTRY,LBN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,5,5,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Lebanon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7407278,TB_rdst_num,COUNTRY,PRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,22,22,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Puerto Rico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7412249,TB_rdst_num,COUNTRY,CHN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,35 200,35200,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,China,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7413876,TB_rdst_num,COUNTRY,NPL,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,11 863,11863,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Nepal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7414585,TB_rdst_num,COUNTRY,HND,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,776,776,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Honduras,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7416671,TB_rdst_num,COUNTRY,LBN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,405,405,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Lebanon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7420225,TB_rdst_num,COUNTRY,CHE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Switzerland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7423647,TB_rdst_num,COUNTRY,CIV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1598,1598,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Cote d'Ivoire,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7426785,TB_rdst_num,COUNTRY,JPN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,7533,7533,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Japan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7448808,TB_rdst_num,COUNTRY,AUS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,42,42,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Australia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7452825,TB_rdst_num,COUNTRY,COG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,89,89,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7454021,TB_rdst_num,COUNTRY,SOM,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,40,40,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Somalia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7454668,TB_rdst_num,COUNTRY,MNP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,22,22,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Northern Mariana Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7454878,TB_rdst_num,COUNTRY,TCD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,9,9,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Chad,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7466271,TB_rdst_num,COUNTRY,CHE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,267,267,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Switzerland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7487771,TB_rdst_num,COUNTRY,SLB,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Solomon Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7489941,TB_rdst_num,COUNTRY,TON,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Tonga,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7496747,TB_rdst_num,COUNTRY,STP,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Sao Tome and Principe,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7503096,TB_rdst_num,COUNTRY,PAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,54,54,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Panama,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7508696,TB_rdst_num,COUNTRY,VCT,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7508986,TB_rdst_num,COUNTRY,FIN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Finland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7517406,TB_rdst_num,COUNTRY,LKA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1087,1087,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Sri Lanka,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7517468,TB_rdst_num,COUNTRY,EST,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,13,13,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Estonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7524116,TB_rdst_num,COUNTRY,SOM,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,51,51,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Somalia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7532492,TB_rdst_num,COUNTRY,UZB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,2013,2013,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uzbekistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7534911,TB_rdst_num,COUNTRY,ISR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,105,105,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Israel,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7538364,TB_rdst_num,COUNTRY,ESP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1046,1046,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Spain,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7539454,TB_rdst_num,COUNTRY,BRA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,3641,3641,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Brazil,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7550844,TB_rdst_num,COUNTRY,CUB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,58,58,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cuba,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7558067,TB_rdst_num,COUNTRY,JPN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,287,287,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Japan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7558396,TB_rdst_num,COUNTRY,CIV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1307,1307,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Cote d'Ivoire,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7558983,TB_rdst_num,COUNTRY,ISL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Iceland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7559865,TB_rdst_num,COUNTRY,MNG,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1491,1491,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Mongolia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7577038,TB_rdst_num,COUNTRY,GHA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,7413,7413,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ghana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7588162,TB_rdst_num,COUNTRY,SYC,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,9,9,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Seychelles,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7589001,TB_rdst_num,COUNTRY,GUM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Guam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7613654,TB_rdst_num,COUNTRY,LBY,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,332,332,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Libya,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7614372,TB_rdst_num,COUNTRY,MUS,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,83,83,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mauritius,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7622575,TB_rdst_num,COUNTRY,DOM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,220,220,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Dominican Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7629019,TB_rdst_num,COUNTRY,MLI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,232,232,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Mali,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7635614,TB_rdst_num,COUNTRY,USA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,4370,4370,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,United States of America,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7646180,TB_rdst_num,COUNTRY,SVK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Slovakia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7647953,TB_rdst_num,COUNTRY,VCT,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7651854,TB_rdst_num,COUNTRY,MMR,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,6051,6051,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Myanmar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7653424,TB_rdst_num,COUNTRY,NPL,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,7821,7821,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Nepal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7664813,TB_rdst_num,COUNTRY,GUY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,241,241,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Guyana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7680360,TB_rdst_num,COUNTRY,DOM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1089,1089,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Dominican Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7691172,TB_rdst_num,COUNTRY,CHL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,221,221,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Chile,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7691215,TB_rdst_num,COUNTRY,SSD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,South Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7697765,TB_rdst_num,COUNTRY,BEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,211,211,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Benin,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7701389,TB_rdst_num,COUNTRY,PER,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,1999,1999,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Peru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7704360,TB_rdst_num,COUNTRY,DNK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,13,13,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Denmark,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7708062,TB_rdst_num,COUNTRY,CPV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,98,98,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Cabo Verde,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7709496,TB_rdst_num,COUNTRY,BGD,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,5892,5892,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bangladesh,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7713770,TB_rdst_num,COUNTRY,BRB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Barbados,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7713981,TB_rdst_num,COUNTRY,HUN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,36,36,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Hungary,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7714893,TB_rdst_num,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,30,30,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Saudi Arabia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7729117,TB_rdst_num,COUNTRY,TON,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Tonga,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7733763,TB_rdst_num,COUNTRY,PLW,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Palau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7743491,TB_rdst_num,COUNTRY,MDV,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Maldives,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7747559,TB_rdst_num,COUNTRY,LAO,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,3810,3810,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Lao People's Democratic Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7769517,TB_rdst_num,COUNTRY,BRA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,4800,4800,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Brazil,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7774905,TB_rdst_num,COUNTRY,CYP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,47,47,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Cyprus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7780636,TB_rdst_num,COUNTRY,NOR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,9,9,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Norway,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7784675,TB_rdst_num,COUNTRY,POL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,389,389,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Poland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7787440,TB_rdst_num,COUNTRY,FIN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Finland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7794423,TB_rdst_num,COUNTRY,BIH,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,27,27,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bosnia and Herzegovina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7803778,TB_rdst_num,COUNTRY,ATG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Antigua and Barbuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7804197,TB_rdst_num,COUNTRY,UKR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,12 349,12349,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ukraine,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7811138,TB_rdst_num,COUNTRY,GMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,117,117,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Gambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7827541,TB_rdst_num,COUNTRY,ZAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,10 204,10204,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,South Africa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7851843,TB_rdst_num,COUNTRY,TUV,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Tuvalu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7854952,TB_rdst_num,COUNTRY,MOZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,1961,1961,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Mozambique,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7860502,TB_rdst_num,COUNTRY,MLT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Malta,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7872046,TB_rdst_num,COUNTRY,SMR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,San Marino,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7873708,TB_rdst_num,COUNTRY,ASM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,American Samoa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7874505,TB_rdst_num,COUNTRY,BFA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,197,197,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Burkina Faso,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7875748,TB_rdst_num,COUNTRY,THA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,3696,3696,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Thailand,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7878920,TB_rdst_num,COUNTRY,HKG,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,159,159,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,"China, Hong Kong Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7885238,TB_rdst_num,COUNTRY,AUS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,41,41,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Australia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7885312,TB_rdst_num,COUNTRY,BLR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1015,1015,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Belarus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7885704,TB_rdst_num,COUNTRY,ISL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Iceland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7888392,TB_rdst_num,COUNTRY,ARG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,318,318,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Argentina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7900480,TB_rdst_num,COUNTRY,ALB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,59,59,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Albania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7901952,TB_rdst_num,COUNTRY,CIV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,945,945,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cote d'Ivoire,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7904776,TB_rdst_num,COUNTRY,GAB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,533,533,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Gabon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7915121,TB_rdst_num,COUNTRY,NLD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,13,13,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Netherlands (Kingdom of the),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7942449,TB_rdst_num,COUNTRY,KAZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,5121,5121,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Kazakhstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7943663,TB_rdst_num,COUNTRY,MYS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,11 480,11480,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Malaysia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7946512,TB_rdst_num,COUNTRY,CHN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,235 901,235901,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,China,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7952549,TB_rdst_num,COUNTRY,ASM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,American Samoa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7954425,TB_rdst_num,COUNTRY,MMR,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,38 513,38513,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Myanmar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7962776,TB_rdst_num,COUNTRY,FRA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,France,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7967701,TB_rdst_num,COUNTRY,CAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,251,251,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Central African Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7969738,TB_rdst_num,COUNTRY,BTN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bhutan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7976741,TB_rdst_num,COUNTRY,CHE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,9,9,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Switzerland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7980321,TB_rdst_num,COUNTRY,IRQ,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,108,108,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Iraq,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7987457,TB_rdst_num,COUNTRY,ERI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,622,622,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Eritrea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8012180,TB_rdst_num,COUNTRY,EGY,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,3360,3360,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Egypt,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8014716,TB_rdst_num,COUNTRY,STP,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Sao Tome and Principe,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8016059,TB_rdst_num,COUNTRY,MNE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Montenegro,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8018141,TB_rdst_num,COUNTRY,TJK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,305,305,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Tajikistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8021620,TB_rdst_num,COUNTRY,GNB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,16,16,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Guinea-Bissau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8028370,TB_rdst_num,COUNTRY,GAB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,637,637,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Gabon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8029159,TB_rdst_num,COUNTRY,TZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,21 772,21772,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,United Republic of Tanzania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8032615,TB_rdst_num,COUNTRY,ETH,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,21 240,21240,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Ethiopia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8034238,TB_rdst_num,COUNTRY,MKD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,19,19,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,North Macedonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8034344,TB_rdst_num,COUNTRY,ZMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,15 390,15390,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Zambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8035290,TB_rdst_num,COUNTRY,SLE,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,4227,4227,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Sierra Leone,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8037561,TB_rdst_num,COUNTRY,CHL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,173,173,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Chile,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8045966,TB_rdst_num,COUNTRY,MNG,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,971,971,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Mongolia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8046647,TB_rdst_num,COUNTRY,RUS,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,27 960,27960,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Russian Federation,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8050654,TB_rdst_num,COUNTRY,SYR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,63,63,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Syrian Arab Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8065837,TB_rdst_num,COUNTRY,JOR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Jordan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8067661,TB_rdst_num,COUNTRY,CAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,660,660,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Central African Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8073396,TB_rdst_num,COUNTRY,ARM,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,48,48,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Armenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8076572,TB_rdst_num,COUNTRY,MDV,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,62,62,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Maldives,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8077243,TB_rdst_num,COUNTRY,LUX,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Luxembourg,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8084889,TB_rdst_num,COUNTRY,CYM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cayman Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8090210,TB_rdst_num,COUNTRY,CRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,289,289,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Costa Rica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8091644,TB_rdst_num,COUNTRY,SUR,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,8,8,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Suriname,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8093214,TB_rdst_num,COUNTRY,SEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,596,596,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Senegal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8102705,TB_rdst_num,COUNTRY,COL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,289,289,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Colombia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8114012,TB_rdst_num,COUNTRY,FSM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Micronesia (Federated States of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8117539,TB_rdst_num,COUNTRY,PLW,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Palau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8122003,TB_rdst_num,COUNTRY,GEO,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,443,443,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Georgia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8124478,TB_rdst_num,COUNTRY,ARG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,2309,2309,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Argentina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8125879,TB_rdst_num,COUNTRY,TJK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,2487,2487,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Tajikistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8142907,TB_rdst_num,COUNTRY,MAC,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,203,203,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,"China, Macao Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8150047,TB_rdst_num,COUNTRY,LAO,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,53,53,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Lao People's Democratic Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8159651,TB_rdst_num,COUNTRY,MNE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,9,9,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Montenegro,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8166821,TB_rdst_num,COUNTRY,ZMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1487,1487,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Zambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8172411,TB_rdst_num,COUNTRY,TZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,26 624,26624,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,United Republic of Tanzania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8173398,TB_rdst_num,COUNTRY,BLZ,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,5,5,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Belize,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8174515,TB_rdst_num,COUNTRY,SDN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,290,290,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8180724,TB_rdst_num,COUNTRY,ERI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,46,46,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Eritrea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8210304,TB_rdst_num,COUNTRY,KOR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,3183,3183,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Republic of Korea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8222461,TB_rdst_num,COUNTRY,CYM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cayman Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8234665,TB_rdst_num,COUNTRY,TON,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Tonga,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8238339,TB_rdst_num,COUNTRY,GRL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Greenland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8241822,TB_rdst_num,COUNTRY,TJK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,652,652,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Tajikistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8242095,TB_rdst_num,COUNTRY,MOZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,34 643,34643,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Mozambique,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8248969,TB_rdst_num,COUNTRY,PHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,17 250,17250,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Philippines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8249729,TB_rdst_num,COUNTRY,COL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,191,191,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Colombia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8250341,TB_rdst_num,COUNTRY,ALB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,154,154,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Albania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8251012,TB_rdst_num,COUNTRY,NRU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,14,14,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Nauru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8259412,TB_rdst_num,COUNTRY,DMA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Dominica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8262435,TB_rdst_num,COUNTRY,VUT,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Vanuatu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8273232,TB_rdst_num,COUNTRY,GUM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,44,44,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Guam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8286595,TB_rdst_num,COUNTRY,CYP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,25,25,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cyprus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8287629,TB_rdst_num,COUNTRY,ZWE,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,9240,9240,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Zimbabwe,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8288600,TB_rdst_num,COUNTRY,ESP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,702,702,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Spain,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8292491,TB_rdst_num,COUNTRY,GHA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,619,619,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ghana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8298566,TB_rdst_num,COUNTRY,GUY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,84,84,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Guyana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8306167,TB_rdst_num,COUNTRY,AND,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Andorra,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8310667,TB_rdst_num,COUNTRY,GRC,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,120,120,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Greece,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8316655,TB_rdst_num,COUNTRY,BRN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Brunei Darussalam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8319737,TB_rdst_num,COUNTRY,TGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,194,194,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Togo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8325383,TB_rdst_num,COUNTRY,NER,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,804,804,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Niger,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8331608,TB_rdst_num,COUNTRY,NAM,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,776,776,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Namibia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8334867,TB_rdst_num,COUNTRY,MEX,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,53,53,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Mexico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8343901,TB_rdst_num,COUNTRY,THA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,29 104,29104,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Thailand,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8350341,TB_rdst_num,COUNTRY,JAM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Jamaica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8360039,TB_rdst_num,COUNTRY,RWA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,3090,3090,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Rwanda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8362632,TB_rdst_num,COUNTRY,KGZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,1003,1003,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Kyrgyzstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8365379,TB_rdst_num,COUNTRY,HND,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,902,902,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Honduras,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8370024,TB_rdst_num,COUNTRY,VUT,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,43,43,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Vanuatu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8375629,TB_rdst_num,COUNTRY,JAM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,49,49,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Jamaica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8376410,TB_rdst_num,COUNTRY,LBN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,12,12,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Lebanon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8383992,TB_rdst_num,COUNTRY,COG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,258,258,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8389172,TB_rdst_num,COUNTRY,KEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,24 832,24832,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Kenya,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8392044,TB_rdst_num,COUNTRY,NER,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,205,205,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Niger,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8392302,TB_rdst_num,COUNTRY,IDN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,15 437,15437,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Indonesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8396833,TB_rdst_num,COUNTRY,NAM,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,971,971,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Namibia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8399197,TB_rdst_num,COUNTRY,BRA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,23 759,23759,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Brazil,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8405151,TB_rdst_num,COUNTRY,GEO,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,267,267,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Georgia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8407523,TB_rdst_num,COUNTRY,SEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,800,800,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Senegal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8407921,TB_rdst_num,COUNTRY,GUY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,287,287,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Guyana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8414582,TB_rdst_num,COUNTRY,CPV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,50,50,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cabo Verde,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8419064,TB_rdst_num,COUNTRY,NLD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,354,354,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Netherlands (Kingdom of the),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8426835,TB_rdst_num,COUNTRY,TUN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,370,370,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Tunisia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8437429,TB_rdst_num,COUNTRY,LVA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,24,24,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Latvia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8442951,TB_rdst_num,COUNTRY,NIU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Niue,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8443047,TB_rdst_num,COUNTRY,NOR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,134,134,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Norway,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8448633,TB_rdst_num,COUNTRY,ISR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Israel,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8454812,TB_rdst_num,COUNTRY,FRA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,243,243,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,France,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8469080,TB_rdst_num,COUNTRY,JAM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,16,16,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Jamaica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8474005,TB_rdst_num,COUNTRY,DJI,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,75,75,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Djibouti,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8474587,TB_rdst_num,COUNTRY,TGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1332,1332,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Togo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8486760,TB_rdst_num,COUNTRY,COL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,356,356,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Colombia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8495097,TB_rdst_num,COUNTRY,THA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,2441,2441,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Thailand,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8507081,TB_rdst_num,COUNTRY,WLF,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Wallis and Futuna Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8517224,TB_rdst_num,COUNTRY,SYR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,906,906,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Syrian Arab Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8528621,TB_rdst_num,COUNTRY,GTM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,732,732,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Guatemala,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8532286,TB_rdst_num,COUNTRY,GHA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,7896,7896,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ghana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8539452,TB_rdst_num,COUNTRY,SGP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1117,1117,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Singapore,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8542318,TB_rdst_num,COUNTRY,NPL,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,1514,1514,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Nepal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8550890,TB_rdst_num,COUNTRY,UKR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,4025,4025,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ukraine,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8551088,TB_rdst_num,COUNTRY,TZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,18 673,18673,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,United Republic of Tanzania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8557096,TB_rdst_num,COUNTRY,ASM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,American Samoa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8559743,TB_rdst_num,COUNTRY,CAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,251,251,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Central African Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8565593,TB_rdst_num,COUNTRY,PRK,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,3204,3204,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Democratic People's Republic of Korea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8566233,TB_rdst_num,COUNTRY,ISR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,129,129,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Israel,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8569493,TB_rdst_num,COUNTRY,ROU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,6062,6062,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Romania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8583634,TB_rdst_num,COUNTRY,MAC,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,234,234,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,"China, Macao Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8589976,TB_rdst_num,COUNTRY,ATG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Antigua and Barbuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8590612,TB_rdst_num,COUNTRY,AZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,2743,2743,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Azerbaijan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8599084,TB_rdst_num,COUNTRY,VEN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,198,198,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8601475,TB_rdst_num,COUNTRY,PRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Puerto Rico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8604807,TB_rdst_num,COUNTRY,HRV,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,62,62,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Croatia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8608752,TB_rdst_num,COUNTRY,AZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1973,1973,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Azerbaijan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8616036,TB_rdst_num,COUNTRY,KWT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,299,299,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Kuwait,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8617093,TB_rdst_num,COUNTRY,ESP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,602,602,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Spain,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8618876,TB_rdst_num,COUNTRY,QAT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,335,335,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Qatar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8622475,TB_rdst_num,COUNTRY,QAT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Qatar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8622893,TB_rdst_num,COUNTRY,SDN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1042,1042,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8627973,TB_rdst_num,COUNTRY,DZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,13,13,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Algeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8629152,TB_rdst_num,COUNTRY,KEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,32 771,32771,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Kenya,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8630139,TB_rdst_num,COUNTRY,BHR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,79,79,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bahrain,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8639348,TB_rdst_num,COUNTRY,NLD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,15,15,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Netherlands (Kingdom of the),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8641510,TB_rdst_num,COUNTRY,HRV,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Croatia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8648422,TB_rdst_num,COUNTRY,PRT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,482,482,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Portugal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8650475,TB_rdst_num,COUNTRY,FJI,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,131,131,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Fiji,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8654969,TB_rdst_num,COUNTRY,IND,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,673 008,673008,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,India,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8658444,TB_rdst_num,COUNTRY,PAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,526,526,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Panama,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8659740,TB_rdst_num,COUNTRY,TJK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,340,340,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Tajikistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8661301,TB_rdst_num,COUNTRY,MDG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,913,913,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Madagascar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8667032,TB_rdst_num,COUNTRY,VNM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,8238,8238,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Viet Nam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8676336,TB_rdst_num,COUNTRY,ETH,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,41 164,41164,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ethiopia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8680107,TB_rdst_num,COUNTRY,NLD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,326,326,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Netherlands (Kingdom of the),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8681063,TB_rdst_num,COUNTRY,GNB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,24,24,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Guinea-Bissau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8689070,TB_rdst_num,COUNTRY,TUV,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Tuvalu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8690011,TB_rdst_num,COUNTRY,ERI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,74,74,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Eritrea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8690344,TB_rdst_num,COUNTRY,TJK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,550,550,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Tajikistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8691845,TB_rdst_num,COUNTRY,COD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,3738,3738,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Democratic Republic of the Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8697149,TB_rdst_num,COUNTRY,FSM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,27,27,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Micronesia (Federated States of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8708649,TB_rdst_num,COUNTRY,BMU,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Bermuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8730036,TB_rdst_num,COUNTRY,WLF,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Wallis and Futuna Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8756314,TB_rdst_num,COUNTRY,MKD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,81,81,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,North Macedonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8762151,TB_rdst_num,COUNTRY,FIN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Finland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8762258,TB_rdst_num,COUNTRY,TKM,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,295,295,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Turkmenistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8762535,TB_rdst_num,COUNTRY,GBR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1546,1546,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8766760,TB_rdst_num,COUNTRY,TKM,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,541,541,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Turkmenistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8766778,TB_rdst_num,COUNTRY,CYP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cyprus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8779734,TB_rdst_num,COUNTRY,HND,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1061,1061,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Honduras,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8779956,TB_rdst_num,COUNTRY,BEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Benin,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8780524,TB_rdst_num,COUNTRY,LVA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,160,160,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Latvia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8784286,TB_rdst_num,COUNTRY,KHM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,246,246,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cambodia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8785764,TB_rdst_num,COUNTRY,MNP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Northern Mariana Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8791701,TB_rdst_num,COUNTRY,JOR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Jordan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8794286,TB_rdst_num,COUNTRY,FIN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Finland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8803872,TB_rdst_num,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,6676,6676,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Pakistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8817148,TB_rdst_num,COUNTRY,ECU,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,446,446,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Ecuador,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8832125,TB_rdst_num,COUNTRY,BDI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1272,1272,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Burundi,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8834657,TB_rdst_num,COUNTRY,SYR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,38,38,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Syrian Arab Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8835512,TB_rdst_num,COUNTRY,BTN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,26,26,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Bhutan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8847215,TB_rdst_num,COUNTRY,EST,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,104,104,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Estonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8850959,TB_rdst_num,COUNTRY,LKA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,421,421,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sri Lanka,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8851694,TB_rdst_num,COUNTRY,KAZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,4858,4858,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Kazakhstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8856373,TB_rdst_num,COUNTRY,KIR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,12,12,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Kiribati,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8864162,TB_rdst_num,COUNTRY,KIR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Kiribati,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8864863,TB_rdst_num,COUNTRY,CHE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,261,261,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Switzerland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8869484,TB_rdst_num,COUNTRY,BRA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,24 855,24855,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Brazil,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8902304,TB_rdst_num,COUNTRY,BHS,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,20,20,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bahamas,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8916575,TB_rdst_num,COUNTRY,NIC,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,113,113,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Nicaragua,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8918549,TB_rdst_num,COUNTRY,PRT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,465,465,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Portugal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8937684,TB_rdst_num,COUNTRY,TUV,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,19,19,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Tuvalu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8941063,TB_rdst_num,COUNTRY,KGZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1932,1932,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Kyrgyzstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8943617,TB_rdst_num,COUNTRY,EGY,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,3506,3506,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Egypt,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8943816,TB_rdst_num,COUNTRY,UZB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,4828,4828,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uzbekistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8944426,TB_rdst_num,COUNTRY,SOM,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,4443,4443,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Somalia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8952453,TB_rdst_num,COUNTRY,EST,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,21,21,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Estonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8955856,TB_rdst_num,COUNTRY,SWE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,8,8,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Sweden,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8967781,TB_rdst_num,COUNTRY,BFA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,295,295,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Burkina Faso,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8971331,TB_rdst_num,COUNTRY,COD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,3016,3016,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Democratic Republic of the Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8973841,TB_rdst_num,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,11 152,11152,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Pakistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8977939,TB_rdst_num,COUNTRY,ARM,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,82,82,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Armenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8986578,TB_rdst_num,COUNTRY,PRT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,34,34,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Portugal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8987814,TB_rdst_num,COUNTRY,VEN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,390,390,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8994887,TB_rdst_num,COUNTRY,GUY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,57,57,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Guyana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9002368,TB_rdst_num,COUNTRY,ISL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Iceland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9003309,TB_rdst_num,COUNTRY,BMU,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bermuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9008357,TB_rdst_num,COUNTRY,CIV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,995,995,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cote d'Ivoire,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9013431,TB_rdst_num,COUNTRY,GRC,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Greece,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9014326,TB_rdst_num,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Arab Emirates,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9018283,TB_rdst_num,COUNTRY,SRB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,327,327,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Serbia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9053304,TB_rdst_num,COUNTRY,GMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,9,9,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Gambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9068755,TB_rdst_num,COUNTRY,GMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,117,117,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Gambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9072178,TB_rdst_num,COUNTRY,CHE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,24,24,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Switzerland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9073131,TB_rdst_num,COUNTRY,SWE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Sweden,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9076450,TB_rdst_num,COUNTRY,IND,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,270 825,270825,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,India,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9078277,TB_rdst_num,COUNTRY,BTN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,52,52,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Bhutan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9089702,TB_rdst_num,COUNTRY,SVK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,65,65,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Slovakia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9090022,TB_rdst_num,COUNTRY,WSM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,13,13,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Samoa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9092362,TB_rdst_num,COUNTRY,CHE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,15,15,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Switzerland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9099608,TB_rdst_num,COUNTRY,MNG,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,418,418,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Mongolia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9107226,TB_rdst_num,COUNTRY,ARG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,341,341,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Argentina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9107535,TB_rdst_num,COUNTRY,EGY,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,2815,2815,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Egypt,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9126751,TB_rdst_num,COUNTRY,ETH,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,36 265,36265,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ethiopia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9136362,TB_rdst_num,COUNTRY,SEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,674,674,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Senegal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9149412,TB_rdst_num,COUNTRY,GRC,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,17,17,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Greece,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9163023,TB_rdst_num,COUNTRY,COG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,333,333,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9172157,TB_rdst_num,COUNTRY,CHL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,179,179,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Chile,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9173005,TB_rdst_num,COUNTRY,NLD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,16,16,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Netherlands (Kingdom of the),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9173444,TB_rdst_num,COUNTRY,NRU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Nauru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9191206,TB_rdst_num,COUNTRY,UKR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,9237,9237,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Ukraine,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9192295,TB_rdst_num,COUNTRY,CIV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,1294,1294,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cote d'Ivoire,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9194795,TB_rdst_num,COUNTRY,SRB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,27,27,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Serbia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9202616,TB_rdst_num,COUNTRY,URY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,510,510,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Uruguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9203381,TB_rdst_num,COUNTRY,LVA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,364,364,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Latvia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9209856,TB_rdst_num,COUNTRY,KIR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,9,9,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Kiribati,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9217858,TB_rdst_num,COUNTRY,LSO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,385,385,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Lesotho,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9218126,TB_rdst_num,COUNTRY,GRC,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,17,17,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Greece,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9222544,TB_rdst_num,COUNTRY,DOM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,415,415,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Dominican Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9235101,TB_rdst_num,COUNTRY,ITA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1165,1165,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Italy,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9246465,TB_rdst_num,COUNTRY,CIV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,8494,8494,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Cote d'Ivoire,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9246910,TB_rdst_num,COUNTRY,TTO,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,57,57,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Trinidad and Tobago,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9249001,TB_rdst_num,COUNTRY,FIN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Finland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9249229,TB_rdst_num,COUNTRY,CMR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,1244,1244,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Cameroon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9256535,TB_rdst_num,COUNTRY,ZWE,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,7361,7361,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Zimbabwe,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9260361,TB_rdst_num,COUNTRY,MYS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,620,620,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Malaysia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9273188,TB_rdst_num,COUNTRY,TUN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1051,1051,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Tunisia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9275793,TB_rdst_num,COUNTRY,BRB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Barbados,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9297594,TB_rdst_num,COUNTRY,PER,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,2622,2622,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Peru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9307686,TB_rdst_num,COUNTRY,NOR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Norway,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9312147,TB_rdst_num,COUNTRY,AGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,2460,2460,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Angola,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9314492,TB_rdst_num,COUNTRY,AGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,358,358,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Angola,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9315555,TB_rdst_num,COUNTRY,TTO,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,19,19,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Trinidad and Tobago,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9320746,TB_rdst_num,COUNTRY,TUR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,4719,4719,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,TÃ¼rkiye,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9328821,TB_rdst_num,COUNTRY,LSO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,346,346,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Lesotho,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9335437,TB_rdst_num,COUNTRY,IDN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,22 418,22418,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Indonesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9335788,TB_rdst_num,COUNTRY,NGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,65 539,65539,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Nigeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9337423,TB_rdst_num,COUNTRY,SVK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,98,98,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovakia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9337631,TB_rdst_num,COUNTRY,BLR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1490,1490,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Belarus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9347574,TB_rdst_num,COUNTRY,IRL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9350919,TB_rdst_num,COUNTRY,PLW,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Palau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9351611,TB_rdst_num,COUNTRY,VUT,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,52,52,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Vanuatu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9355077,TB_rdst_num,COUNTRY,GTM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,235,235,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Guatemala,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9357632,TB_rdst_num,COUNTRY,ASM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,American Samoa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9369782,TB_rdst_num,COUNTRY,POL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,443,443,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Poland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9373277,TB_rdst_num,COUNTRY,VEN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,226,226,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9386278,TB_rdst_num,COUNTRY,IRL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,96,96,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9390679,TB_rdst_num,COUNTRY,BWA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,149,149,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Botswana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9393199,TB_rdst_num,COUNTRY,JOR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,8,8,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Jordan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9400106,TB_rdst_num,COUNTRY,NGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,48 309,48309,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Nigeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9406065,TB_rdst_num,COUNTRY,BMU,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Bermuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9412326,TB_rdst_num,COUNTRY,HKG,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,2285,2285,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,"China, Hong Kong Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9413912,TB_rdst_num,COUNTRY,MDA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,512,512,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Republic of Moldova,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9422110,TB_rdst_num,COUNTRY,BIH,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,399,399,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bosnia and Herzegovina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9424085,TB_rdst_num,COUNTRY,MYS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,650,650,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Malaysia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9426166,TB_rdst_num,COUNTRY,GIN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,159,159,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9427493,TB_rdst_num,COUNTRY,IND,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,557 456,557456,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,India,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9431571,TB_rdst_num,COUNTRY,NPL,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,8135,8135,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Nepal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9436584,TB_rdst_num,COUNTRY,BHS,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,12,12,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Bahamas,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9446255,TB_rdst_num,COUNTRY,CMR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,6435,6435,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cameroon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9479600,TB_rdst_num,COUNTRY,LTU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,725,725,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Lithuania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9489938,TB_rdst_num,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,71 841,71841,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Pakistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9494167,TB_rdst_num,COUNTRY,NIC,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,609,609,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Nicaragua,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9502437,TB_rdst_num,COUNTRY,AUT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,12,12,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Austria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9509333,TB_rdst_num,COUNTRY,FSM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Micronesia (Federated States of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9513612,TB_rdst_num,COUNTRY,AGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1100,1100,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Angola,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9516369,TB_rdst_num,COUNTRY,GNQ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,92,92,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Equatorial Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9523963,TB_rdst_num,COUNTRY,AUT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,173,173,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Austria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9525636,TB_rdst_num,COUNTRY,DNK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,160,160,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Denmark,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9528858,TB_rdst_num,COUNTRY,WSM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Samoa,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9539815,TB_rdst_num,COUNTRY,BRN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,229,229,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Brunei Darussalam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9541357,TB_rdst_num,COUNTRY,LUX,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Luxembourg,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9547068,TB_rdst_num,COUNTRY,BGR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,84,84,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bulgaria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9548032,TB_rdst_num,COUNTRY,ECU,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,2900,2900,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ecuador,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9548190,TB_rdst_num,COUNTRY,UKR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,12 632,12632,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Ukraine,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9552136,TB_rdst_num,COUNTRY,AUS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,688,688,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Australia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9556735,TB_rdst_num,COUNTRY,GIN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,338,338,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9559571,TB_rdst_num,COUNTRY,BIH,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,255,255,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Bosnia and Herzegovina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9579065,TB_rdst_num,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,12 568,12568,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Pakistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9582846,TB_rdst_num,COUNTRY,PHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,5048,5048,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Philippines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9592362,TB_rdst_num,COUNTRY,MAC,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,30,30,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,"China, Macao Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9595059,TB_rdst_num,COUNTRY,LUX,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Luxembourg,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9604159,TB_rdst_num,COUNTRY,GNQ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,77,77,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Equatorial Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9608957,TB_rdst_num,COUNTRY,BRB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Barbados,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9616077,TB_rdst_num,COUNTRY,MMR,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,6557,6557,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Myanmar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9628414,TB_rdst_num,COUNTRY,NLD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Netherlands (Kingdom of the),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9639132,TB_rdst_num,COUNTRY,LBN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,327,327,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Lebanon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9643407,TB_rdst_num,COUNTRY,NIU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Niue,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9643943,TB_rdst_num,COUNTRY,GUM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,51,51,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Guam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9644255,TB_rdst_num,COUNTRY,MHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Marshall Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9651934,TB_rdst_num,COUNTRY,UGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,2210,2210,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Uganda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9655293,TB_rdst_num,COUNTRY,BRB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Barbados,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9659892,TB_rdst_num,COUNTRY,DMA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Dominica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9660080,TB_rdst_num,COUNTRY,CHN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,33 946,33946,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,China,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9686672,TB_rdst_num,COUNTRY,BHR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,93,93,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Bahrain,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9690769,TB_rdst_num,COUNTRY,MUS,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,118,118,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mauritius,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9703821,TB_rdst_num,COUNTRY,BRB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Barbados,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9709673,TB_rdst_num,COUNTRY,CPV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,77,77,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cabo Verde,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9721992,TB_rdst_num,COUNTRY,AGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,597,597,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Angola,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9726120,TB_rdst_num,COUNTRY,PRI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Puerto Rico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9731331,TB_rdst_num,COUNTRY,NAM,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,3803,3803,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Namibia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9748172,TB_rdst_num,COUNTRY,MYS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,976,976,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malaysia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9753751,TB_rdst_num,COUNTRY,SUR,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,69,69,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Suriname,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9792555,TB_rdst_num,COUNTRY,HND,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,93,93,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Honduras,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9798347,TB_rdst_num,COUNTRY,MHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,30,30,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Marshall Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9801093,TB_rdst_num,COUNTRY,KAZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,2216,2216,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Kazakhstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9802805,TB_rdst_num,COUNTRY,VCT,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9806998,TB_rdst_num,COUNTRY,IRQ,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,618,618,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Iraq,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9810639,TB_rdst_num,COUNTRY,KNA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Saint Kitts and Nevis,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9815314,TB_rdst_num,COUNTRY,GTM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,174,174,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Guatemala,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9825344,TB_rdst_num,COUNTRY,BIH,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,306,306,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Bosnia and Herzegovina,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9826188,TB_rdst_num,COUNTRY,SLE,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,2838,2838,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Sierra Leone,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9826722,TB_rdst_num,COUNTRY,UZB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,2087,2087,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Uzbekistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9847544,TB_rdst_num,COUNTRY,ETH,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,2698,2698,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Ethiopia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9863075,TB_rdst_num,COUNTRY,QAT,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Qatar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9866110,TB_rdst_num,COUNTRY,VNM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,40 773,40773,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Viet Nam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9878556,TB_rdst_num,COUNTRY,MDG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,1068,1068,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Madagascar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9880364,TB_rdst_num,COUNTRY,CAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,53,53,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Central African Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9882044,TB_rdst_num,COUNTRY,URY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,81,81,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uruguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9893740,TB_rdst_num,COUNTRY,GMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Gambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9895539,TB_rdst_num,COUNTRY,PSE,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,"occupied Palestinian territory, including east Jerusalem",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9908375,TB_rdst_num,COUNTRY,ALB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,125,125,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Albania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9909102,TB_rdst_num,COUNTRY,VNM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,4583,4583,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Viet Nam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9912162,TB_rdst_num,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,590,590,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Saudi Arabia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9915318,TB_rdst_num,COUNTRY,PSE,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,"occupied Palestinian territory, including east Jerusalem",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9921139,TB_rdst_num,COUNTRY,ESP,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,44,44,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Spain,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9924651,TB_rdst_num,COUNTRY,PHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1027,1027,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Philippines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9929312,TB_rdst_num,COUNTRY,BGR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,476,476,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bulgaria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9937034,TB_rdst_num,COUNTRY,KAZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,3250,3250,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Kazakhstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9954429,TB_rdst_num,COUNTRY,COD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,2494,2494,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Democratic Republic of the Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9956407,TB_rdst_num,COUNTRY,BEL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,39,39,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belgium,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9957260,TB_rdst_num,COUNTRY,FRA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,17,17,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,France,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9968609,TB_rdst_num,COUNTRY,STP,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Sao Tome and Principe,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9971707,TB_rdst_num,COUNTRY,BGD,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,5107,5107,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bangladesh,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9979320,TB_rdst_num,COUNTRY,MNG,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,297,297,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Mongolia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9995927,TB_rdst_num,COUNTRY,CHL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1698,1698,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Chile,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9997538,TB_rdst_num,COUNTRY,NGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,3938,3938,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Nigeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9997634,TB_rdst_num,COUNTRY,NIC,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,396,396,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Nicaragua,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9997997,TB_rdst_num,COUNTRY,TGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1613,1613,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Togo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10015450,TB_rdst_num,COUNTRY,BEL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,40,40,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Belgium,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10020720,TB_rdst_num,COUNTRY,BRN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,14,14,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Brunei Darussalam,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10022696,TB_rdst_num,COUNTRY,PYF,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,French Polynesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10026557,TB_rdst_num,COUNTRY,SSD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,60,60,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,South Sudan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10036320,TB_rdst_num,COUNTRY,COK,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cook Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10045327,TB_rdst_num,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,29,29,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,United Arab Emirates,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10048984,TB_rdst_num,COUNTRY,MNE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,60,60,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Montenegro,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10053251,TB_rdst_num,COUNTRY,KEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,2773,2773,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Kenya,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10080855,TB_rdst_num,COUNTRY,LBR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,1486,1486,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Liberia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10103268,TB_rdst_num,COUNTRY,MAR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,1101,1101,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Morocco,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10109000,TB_rdst_num,COUNTRY,SOM,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,5311,5311,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Somalia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10111460,TB_rdst_num,COUNTRY,MDG,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,8,8,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Madagascar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10115653,TB_rdst_num,COUNTRY,TKL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Tokelau,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10116947,TB_rdst_num,COUNTRY,IRQ,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,2411,2411,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Iraq,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10122502,TB_rdst_num,COUNTRY,ARM,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,233,233,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Armenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10133739,TB_rdst_num,COUNTRY,AFG,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,17 443,17443,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Afghanistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10134960,TB_rdst_num,COUNTRY,COD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,28 577,28577,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Democratic Republic of the Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10137347,TB_rdst_num,COUNTRY,BGD,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,8119,8119,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Bangladesh,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10140482,TB_rdst_num,COUNTRY,AGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,52,52,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Angola,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10153878,TB_rdst_num,COUNTRY,GIN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,204,204,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10154878,TB_rdst_num,COUNTRY,CUB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,190,190,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cuba,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2485,TB_rdst_num,COUNTRY,NRU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Nauru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
15140,TB_rdst_num,COUNTRY,TON,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Tonga,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
34361,TB_rdst_num,COUNTRY,URY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,474,474,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Uruguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
66212,TB_rdst_num,COUNTRY,SLV,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,316,316,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,El Salvador,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
110233,TB_rdst_num,COUNTRY,LBN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Lebanon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
116677,TB_rdst_num,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,35,35,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Arab Emirates,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
141862,TB_rdst_num,COUNTRY,DZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,51,51,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Algeria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
236259,TB_rdst_num,COUNTRY,PHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,111 868,111868,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Philippines,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
249399,TB_rdst_num,COUNTRY,BLZ,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,51,51,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Belize,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
499830,TB_rdst_num,COUNTRY,DEU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,108,108,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Germany,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
518983,TB_rdst_num,COUNTRY,TON,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Tonga,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
525252,TB_rdst_num,COUNTRY,BLR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,523,523,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Belarus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
619586,TB_rdst_num,COUNTRY,HRV,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Croatia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
619847,TB_rdst_num,COUNTRY,CAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,596,596,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Canada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
663896,TB_rdst_num,COUNTRY,GBR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,76,76,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
682813,TB_rdst_num,COUNTRY,GIN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,542,542,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
701656,TB_rdst_num,COUNTRY,BLR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,569,569,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Belarus,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
744521,TB_rdst_num,COUNTRY,NAM,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,863,863,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Namibia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
751307,TB_rdst_num,COUNTRY,SGP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,67,67,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Singapore,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
751502,TB_rdst_num,COUNTRY,AUT,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,12,12,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Austria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
802432,TB_rdst_num,COUNTRY,GEO,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1313,1313,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Georgia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
834067,TB_rdst_num,COUNTRY,SOM,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,41,41,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Somalia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
877836,TB_rdst_num,COUNTRY,EST,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,13,13,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Estonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
896926,TB_rdst_num,COUNTRY,ABW,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Aruba,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
928452,TB_rdst_num,COUNTRY,AND,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Andorra,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
935082,TB_rdst_num,COUNTRY,NLD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,15,15,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Netherlands (Kingdom of the),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
985581,TB_rdst_num,COUNTRY,TUV,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Tuvalu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1086599,TB_rdst_num,COUNTRY,BFA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,806,806,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Burkina Faso,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1174938,TB_rdst_num,COUNTRY,KGZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,698,698,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Kyrgyzstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1263312,TB_rdst_num,COUNTRY,DJI,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,621,621,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Djibouti,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1307458,TB_rdst_num,COUNTRY,KGZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1741,1741,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Kyrgyzstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1307615,TB_rdst_num,COUNTRY,MMR,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,6406,6406,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Myanmar,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1351741,TB_rdst_num,COUNTRY,BOL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,811,811,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Bolivia (Plurinational State of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1358549,TB_rdst_num,COUNTRY,NAM,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,4062,4062,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Namibia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1364409,TB_rdst_num,COUNTRY,EGY,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,2962,2962,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Egypt,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1383392,TB_rdst_num,COUNTRY,FSM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Micronesia (Federated States of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1390253,TB_rdst_num,COUNTRY,MEX,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,232,232,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Mexico,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1414787,TB_rdst_num,COUNTRY,PAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,497,497,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Panama,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1433669,TB_rdst_num,COUNTRY,ZWE,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,10 392,10392,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Zimbabwe,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1433897,TB_rdst_num,COUNTRY,USA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,195,195,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,United States of America,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1440485,TB_rdst_num,COUNTRY,KOR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,13 053,13053,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Republic of Korea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1465682,TB_rdst_num,COUNTRY,MAR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,8129,8129,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Morocco,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1477990,TB_rdst_num,COUNTRY,SYR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,912,912,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Syrian Arab Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1496959,TB_rdst_num,COUNTRY,TZA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,9503,9503,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Republic of Tanzania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1528581,TB_rdst_num,COUNTRY,KAZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,2401,2401,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Kazakhstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1591717,TB_rdst_num,COUNTRY,AUS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,32,32,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Australia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1648710,TB_rdst_num,COUNTRY,SWZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1104,1104,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Eswatini,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1680261,TB_rdst_num,COUNTRY,IDN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,23 539,23539,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Indonesia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1705927,TB_rdst_num,COUNTRY,CPV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,99,99,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Cabo Verde,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1971511,TB_rdst_num,COUNTRY,AZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1911,1911,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Azerbaijan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
1997276,TB_rdst_num,COUNTRY,GMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,47,47,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Gambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2010019,TB_rdst_num,COUNTRY,GNQ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,34,34,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Equatorial Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2066901,TB_rdst_num,COUNTRY,GHA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,8016,8016,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ghana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2098258,TB_rdst_num,COUNTRY,USA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,189,189,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,United States of America,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2262702,TB_rdst_num,COUNTRY,BFA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,495,495,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Burkina Faso,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2295020,TB_rdst_num,COUNTRY,CHE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,220,220,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Switzerland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2452967,TB_rdst_num,COUNTRY,SYR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,705,705,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Syrian Arab Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2453322,TB_rdst_num,COUNTRY,UZB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1868,1868,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Uzbekistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2465480,TB_rdst_num,COUNTRY,TTO,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,92,92,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Trinidad and Tobago,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2529526,TB_rdst_num,COUNTRY,COM,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Comoros,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2661807,TB_rdst_num,COUNTRY,ITA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,67,67,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Italy,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2712379,TB_rdst_num,COUNTRY,LAO,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,139,139,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Lao People's Democratic Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2725149,TB_rdst_num,COUNTRY,MNP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,24,24,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Northern Mariana Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2750417,TB_rdst_num,COUNTRY,GRL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,29,29,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Greenland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2776023,TB_rdst_num,COUNTRY,BTN,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,419,419,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Bhutan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2788560,TB_rdst_num,COUNTRY,NLD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,270,270,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Netherlands (Kingdom of the),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2833036,TB_rdst_num,COUNTRY,BEL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,34,34,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belgium,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2926384,TB_rdst_num,COUNTRY,AZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,2159,2159,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Azerbaijan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
2945819,TB_rdst_num,COUNTRY,KGZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,2282,2282,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Kyrgyzstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3015193,TB_rdst_num,COUNTRY,TUR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,546,546,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,TÃ¼rkiye,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3059651,TB_rdst_num,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,35,35,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Arab Emirates,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3140876,TB_rdst_num,COUNTRY,COL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1861,1861,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Colombia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3147521,TB_rdst_num,COUNTRY,GRD,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Grenada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3241994,TB_rdst_num,COUNTRY,SYC,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,9,9,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Seychelles,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3248954,TB_rdst_num,COUNTRY,STP,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,24,24,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sao Tome and Principe,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3357483,TB_rdst_num,COUNTRY,HRV,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,159,159,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Croatia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3357654,TB_rdst_num,COUNTRY,DMA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Dominica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3357909,TB_rdst_num,COUNTRY,MHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,67,67,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Marshall Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3383209,TB_rdst_num,COUNTRY,BHR,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,80,80,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bahrain,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3474854,TB_rdst_num,COUNTRY,MHL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Marshall Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3785176,TB_rdst_num,COUNTRY,KGZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,1094,1094,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Kyrgyzstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3841896,TB_rdst_num,COUNTRY,MDA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,509,509,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Republic of Moldova,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3879470,TB_rdst_num,COUNTRY,AFG,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,1628,1628,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Afghanistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3879560,TB_rdst_num,COUNTRY,HUN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,142,142,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Hungary,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3911193,TB_rdst_num,COUNTRY,MYS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,12 019,12019,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Malaysia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3917653,TB_rdst_num,COUNTRY,PAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,70,70,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Panama,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
3955511,TB_rdst_num,COUNTRY,BRB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Barbados,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4112833,TB_rdst_num,COUNTRY,MKD,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,North Macedonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4119187,TB_rdst_num,COUNTRY,LBY,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,22,22,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Libya,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4206794,TB_rdst_num,COUNTRY,FRA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,2630,2630,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,France,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4314005,TB_rdst_num,COUNTRY,ATG,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Antigua and Barbuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4326415,TB_rdst_num,COUNTRY,SGP,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,52,52,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Singapore,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4358065,TB_rdst_num,COUNTRY,MLI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,284,284,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mali,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4396424,TB_rdst_num,COUNTRY,ABW,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Aruba,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4413914,TB_rdst_num,COUNTRY,HTI,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,898,898,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Haiti,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4420614,TB_rdst_num,COUNTRY,PER,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,13 453,13453,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Peru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4458444,TB_rdst_num,COUNTRY,GBR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,151,151,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4458592,TB_rdst_num,COUNTRY,KOR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,3122,3122,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Republic of Korea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4471177,TB_rdst_num,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,23,23,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,United Arab Emirates,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4622867,TB_rdst_num,COUNTRY,KIR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,174,174,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Kiribati,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4660588,TB_rdst_num,COUNTRY,CUB,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,340,340,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cuba,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4755946,TB_rdst_num,COUNTRY,BOL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,319,319,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bolivia (Plurinational State of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4806379,TB_rdst_num,COUNTRY,FJI,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,127,127,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Fiji,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4888076,TB_rdst_num,COUNTRY,IND,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,699 062,699062,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,India,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4945404,TB_rdst_num,COUNTRY,POL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,3173,3173,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Poland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4945669,TB_rdst_num,COUNTRY,GNQ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,492,492,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Equatorial Guinea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4970785,TB_rdst_num,COUNTRY,RWA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,273,273,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Rwanda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
4977499,TB_rdst_num,COUNTRY,AND,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Andorra,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5027749,TB_rdst_num,COUNTRY,MDA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1397,1397,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Republic of Moldova,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5034303,TB_rdst_num,COUNTRY,CAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,74,74,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Central African Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5135328,TB_rdst_num,COUNTRY,SEN,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,1001,1001,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Senegal,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5135343,TB_rdst_num,COUNTRY,JAM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Jamaica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5141999,TB_rdst_num,COUNTRY,PRY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,819,819,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Paraguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5242245,TB_rdst_num,COUNTRY,LTU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,96,96,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Lithuania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5242505,TB_rdst_num,COUNTRY,UKR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,5827,5827,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Ukraine,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5248487,TB_rdst_num,COUNTRY,MYS,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,11 360,11360,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malaysia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5248925,TB_rdst_num,COUNTRY,PSE,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,"occupied Palestinian territory, including east Jerusalem",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5331278,TB_rdst_num,COUNTRY,FSM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,27,27,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Micronesia (Federated States of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5488405,TB_rdst_num,COUNTRY,DNK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,155,155,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Denmark,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5494505,TB_rdst_num,COUNTRY,POL,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,333,333,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Poland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5526626,TB_rdst_num,COUNTRY,GEO,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,953,953,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Georgia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5721955,TB_rdst_num,COUNTRY,COD,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,11 274,11274,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Democratic Republic of the Congo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5728859,TB_rdst_num,COUNTRY,DOM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,229,229,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Dominican Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5842606,TB_rdst_num,COUNTRY,NER,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,113,113,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Niger,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5880279,TB_rdst_num,COUNTRY,MCO,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Monaco,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5899614,TB_rdst_num,COUNTRY,MSR,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Montserrat,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
5962665,TB_rdst_num,COUNTRY,BGR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,403,403,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Bulgaria,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6031775,TB_rdst_num,COUNTRY,PER,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,12 771,12771,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Peru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6044393,TB_rdst_num,COUNTRY,CMR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,5161,5161,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Cameroon,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6089265,TB_rdst_num,COUNTRY,IRQ,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,2043,2043,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Iraq,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6107816,TB_rdst_num,COUNTRY,CAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,43,43,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Canada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6157170,TB_rdst_num,COUNTRY,MOZ,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1865,1865,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mozambique,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6251761,TB_rdst_num,COUNTRY,VEN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,283,283,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6264415,TB_rdst_num,COUNTRY,CAF,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,671,671,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Central African Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6410179,TB_rdst_num,COUNTRY,CIV,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1285,1285,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cote d'Ivoire,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6416361,TB_rdst_num,COUNTRY,TON,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,5,5,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Tonga,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6511464,TB_rdst_num,COUNTRY,SXM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Sint Maarten (Dutch part),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6581734,TB_rdst_num,COUNTRY,MDA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,345,345,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Republic of Moldova,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6752106,TB_rdst_num,COUNTRY,HKG,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,2181,2181,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,"China, Hong Kong Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6789688,TB_rdst_num,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,8265,8265,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Pakistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6833268,TB_rdst_num,COUNTRY,ALB,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Albania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6839636,TB_rdst_num,COUNTRY,TUV,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,15,15,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Tuvalu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6877584,TB_rdst_num,COUNTRY,UGA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,1271,1271,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Uganda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6927931,TB_rdst_num,COUNTRY,EST,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,106,106,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Estonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
6965967,TB_rdst_num,COUNTRY,GBR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,1906,1906,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7003871,TB_rdst_num,COUNTRY,GMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Gambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7004404,TB_rdst_num,COUNTRY,DNK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,113,113,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Denmark,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7023413,TB_rdst_num,COUNTRY,EST,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,91,91,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Estonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7029737,TB_rdst_num,COUNTRY,TUV,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Tuvalu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7035602,TB_rdst_num,COUNTRY,NRU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Nauru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7092218,TB_rdst_num,COUNTRY,JAM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,45,45,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Jamaica,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7243805,TB_rdst_num,COUNTRY,BDI,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,25,25,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Burundi,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7243894,TB_rdst_num,COUNTRY,HRV,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Croatia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7357923,TB_rdst_num,COUNTRY,ARM,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,320,320,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Armenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7364680,TB_rdst_num,COUNTRY,COL,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1376,1376,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Colombia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7377548,TB_rdst_num,COUNTRY,NIU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Niue,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7389720,TB_rdst_num,COUNTRY,URY,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,48,48,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Uruguay,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7427942,TB_rdst_num,COUNTRY,JPN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,7249,7249,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Japan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7548293,TB_rdst_num,COUNTRY,KAZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,3831,3831,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Kazakhstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7599079,TB_rdst_num,COUNTRY,GRC,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,153,153,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Greece,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7604913,TB_rdst_num,COUNTRY,MRT,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,47,47,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mauritania,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7668805,TB_rdst_num,COUNTRY,IRN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,2805,2805,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Iran (Islamic Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7719217,TB_rdst_num,COUNTRY,HUN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,23,23,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Hungary,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7763657,TB_rdst_num,COUNTRY,ABW,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Aruba,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7877412,TB_rdst_num,COUNTRY,VUT,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Vanuatu,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7941592,TB_rdst_num,COUNTRY,IND,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,131 162,131162,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,India,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7954070,TB_rdst_num,COUNTRY,DOM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,138,138,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Dominican Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
7997959,TB_rdst_num,COUNTRY,BMU,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bermuda,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8074510,TB_rdst_num,COUNTRY,NAM,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,3335,3335,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Namibia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8144434,TB_rdst_num,COUNTRY,DJI,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,47,47,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Djibouti,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8156939,TB_rdst_num,COUNTRY,SVK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,51,51,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Slovakia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8181926,TB_rdst_num,COUNTRY,TKM,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,300,300,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Turkmenistan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8207535,TB_rdst_num,COUNTRY,SVN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,4,4,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8252220,TB_rdst_num,COUNTRY,THA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,30 077,30077,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Thailand,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8277606,TB_rdst_num,COUNTRY,NRU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Nauru,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8334625,TB_rdst_num,COUNTRY,DEU,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,2064,2064,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Germany,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8353025,TB_rdst_num,COUNTRY,TLS,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Timor-Leste,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8441575,TB_rdst_num,COUNTRY,NOR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,69,69,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Norway,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8454525,TB_rdst_num,COUNTRY,LUX,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,16,16,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Luxembourg,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8498338,TB_rdst_num,COUNTRY,NIU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Niue,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8498573,TB_rdst_num,COUNTRY,NCL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,23,23,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,New Caledonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8504756,TB_rdst_num,COUNTRY,LUX,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Luxembourg,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8631229,TB_rdst_num,COUNTRY,SXM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sint Maarten (Dutch part),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8637719,TB_rdst_num,COUNTRY,DNK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Denmark,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8681470,TB_rdst_num,COUNTRY,SVN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,57,57,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Slovenia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8713050,TB_rdst_num,COUNTRY,SUR,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,78,78,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Suriname,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8750970,TB_rdst_num,COUNTRY,DOM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,308,308,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Dominican Republic,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
8808239,TB_rdst_num,COUNTRY,SLV,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,17,17,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,El Salvador,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9011553,TB_rdst_num,COUNTRY,LBR,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,923,923,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Liberia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9068502,TB_rdst_num,COUNTRY,SWE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2017,NA,NA,NA,NA,NA,NA,252,252,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sweden,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9093781,TB_rdst_num,COUNTRY,TCA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Turks and Caicos Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9100059,TB_rdst_num,COUNTRY,BRA,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,6057,6057,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Brazil,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9169909,TB_rdst_num,COUNTRY,ZMB,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,295,295,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Zambia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9251833,TB_rdst_num,COUNTRY,THA,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,24 250,24250,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Thailand,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9296351,TB_rdst_num,COUNTRY,NCL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2019,NA,NA,NA,NA,NA,NA,16,16,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,New Caledonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9302660,TB_rdst_num,COUNTRY,MAC,NA,YEAR,NA,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,25,25,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,"China, Macao Special Administrative Region",The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9308739,TB_rdst_num,COUNTRY,NOR,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,7,7,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Norway,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9346573,TB_rdst_num,COUNTRY,DNK,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,17,17,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Denmark,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9397374,TB_rdst_num,COUNTRY,SLV,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,819,819,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,El Salvador,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9397380,TB_rdst_num,COUNTRY,RUS,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2018,NA,NA,NA,NA,NA,NA,24 088,24088,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Russian Federation,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9556069,TB_rdst_num,COUNTRY,GHA,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,618,618,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Ghana,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9569241,TB_rdst_num,COUNTRY,BGD,SEAR,YEAR,South-East Asia,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,82 924,82924,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Bangladesh,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9619853,TB_rdst_num,COUNTRY,NIC,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,78,78,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Nicaragua,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9676876,TB_rdst_num,COUNTRY,COK,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cook Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9702003,TB_rdst_num,COUNTRY,FSM,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Micronesia (Federated States of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9752521,TB_rdst_num,COUNTRY,CHN,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,19 099,19099,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,China,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9752804,TB_rdst_num,COUNTRY,KOR,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,2868,2868,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Republic of Korea,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9784731,TB_rdst_num,COUNTRY,CYM,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cayman Islands,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9834977,TB_rdst_num,COUNTRY,NCL,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,24,24,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,New Caledonia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9854166,TB_rdst_num,COUNTRY,TGO,AFR,YEAR,Africa,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,148,148,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Togo,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9879873,TB_rdst_num,COUNTRY,KAZ,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2018,NA,NA,NA,NA,NA,NA,6298,6298,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Kazakhstan,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9892377,TB_rdst_num,COUNTRY,NIU,WPR,YEAR,Western Pacific,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2021,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Niue,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9911171,TB_rdst_num,COUNTRY,IRN,EMR,YEAR,Eastern Mediterranean,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2017,NA,NA,NA,NA,NA,NA,382,382,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Iran (Islamic Republic of),The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
9936698,TB_rdst_num,COUNTRY,HUN,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2020,NA,NA,NA,NA,NA,NA,21,21,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Hungary,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10012559,TB_rdst_num,COUNTRY,FRA,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2020,NA,NA,NA,NA,NA,NA,20,20,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,France,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10069345,TB_rdst_num,COUNTRY,CAN,AMR,YEAR,Americas,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_RETREATED,2019,NA,NA,NA,NA,NA,NA,44,44,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Canada,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
10107342,TB_rdst_num,COUNTRY,CZE,EUR,YEAR,Europe,TB_TREATHISTORY,TB_TREATHISTORY_TB_TREATHISTORY_NEW,2021,NA,NA,NA,NA,NA,NA,239,239,NA,NA,NA,2024-05-06T09:56:42.727+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Czechia,The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.,EN,TB Treatment history
